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ABSTRACT 
In the beginning of the drug approval process, thousands of compounds are tested for 
effectiveness; this is extremely costly and time intensive for companies. Animal models are often 
used in the beginning of the process to test the efficacy of these compounds. However, animal 
models do not match human physiology, making them inaccurate predictors of how the 
compound will perform later on in the drug approval process. Based on this, there is a need for 
an intervention early on in the process to reduce time and cost and increase predictive power. 
Organ-on-a-chip technology is a promising answer to these problems since these devices have 
the ability to host organ and tissue types that are more predictive of human physiology. 
Additionally, these devices can easily test compounds in bulk. To make these systems as robust 
as possible, it is advantageous to incorporate sensing capabilities into the device. The capability 
to sense oxygen is valuable, being that these readings are directly correlated to cellular metabolic 
activity. 
Project SOAR collaborated with Draper, a research and development organization based 
in Cambridge, MA, to integrate real-time oxygen sensing capabilities into Draper’s organ-on-a-
chip device. The goal of this project was to identify and determine a means of incorporating an 
oxygen quenchable sensor format into the existing device. This format must be able to sustain 
the conditions of normal device use including thermal cycling, sterilization, and exposure to cell 
culture media for prolonged periods of time. By working with various possible formats and 
iterating on the best incorporation method, the team was able to create a design able to fulfill all 
of Draper’s required specifications. The final format was comprised of a nanoparticle indicator 
solution that was processed under 1000 lbs of force (450 psi of pressure) at 120 degrees Celsius 
xi 
 
for a period of 15 minutes using a Carver press. By incorporating the nanoparticle format in such 
a way, the team greatly improved the pre-existing standard employed at Draper. 
Compared to Draper’s previous format, the nanoparticles proved to be more versatile, 
showing the ability to have signal intensities that can be fine-tuned to the desired signal strength. 
To verify the capacity to easily utilize this format in Draper’s final device, the team performed a 
wide array of validation testing on this sensor format, as well as the other formats of interest. 
Qualitative optical clarity testing proved that the nanoparticles would be a better format to 
incorporate into the final device compared to the foil and dye formats, both of which 
significantly impeded optical clarity during standard microscopy examination. The concentration 
of nanoparticle solution was not sufficient to achieve an optimal signal intensity above the 50 
mV threshold specified by PyroSciene following the soak test; however, this can be remedied 
easily to allow this format to withstand the current parameters of final device use. The 
nanoparticle format also showed overall successes following the thermal, sterilization, and 
duration tests. Overall, the successes during validation testing further proved that the 
nanoparticles, when processed using the Carver press, are the best sensor format to incorporate 
within Draper’s final device. 
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CHAPTER 1: INTRODUCTION 
Successful development of a single drug typically takes 10 to 12 years and roughly 2.5 
billion dollars [1]. Within this drug development process, nearly 90% of drugs that pass animal 
studies will fail in human clinical trials [2]. This creates a need for a better way to simulate how 
a drug will react, improving upon the animal models that are currently used. To accommodate 
this need, organ-on-a-chip devices employing microfluidic principles have emerged in recent 
years. The principles of microfluidics involve the manipulation of small amounts of fluids using 
micrometer-scale channels [3]. Through microfluidics, pharmacology researchers are better able 
to mimic in vivo conditions and it is possible to inexpensively produce multiple replicates of 
drug tests while minimizing volumes of consumables. The market for organ-on-a-chip devices is 
expected to grow by 69.4% in the next 10 years to a total market of 6.13 billion dollars by 2025 
[4]. 
To accurately simulate in vivo conditions, organ-on-a-chip technology must have analyte 
sensing capabilities to monitor cell viability [5]. There are a variety of analytes that can be 
monitored including oxygen, carbon dioxide, glucose, and pH. Of these, oxygen analytes are the 
most successfully implemented parameter in microfluidics, as they show the capacity to quantify 
the behavior and viability of cell types as well as drug effectiveness [6], [7]. Oxygen levels can 
be measured via mechanical, optical, or electrochemical means; however, optical oxygen sensing 
is the most ideal in cellular environments because it does not contact cell media and does not 
consume the analyte. 
Draper, a not-for-profit research and development company, is in the process of 
developing a 96-well organ-on-a-chip platform with multifunctional capabilities including the 
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sensing of dissolved oxygen. Current methods for oxygen sensing used at Draper are labor 
intensive, low-throughput, and not compatible with microscopy. Their current system uses the 
Piccolo2 oxygen sensor as an optical platform, which operates using red flash technology and a 
sensing foil. The term optical platform refers to the source of the excitation flash and where the 
associated emission is received. Both of these components have been developed by PyroScience 
to acquire an oxygen percentage reading without submerging the Piccolo2’s fiber optic cable in 
the cell media [8]. This system requires that the single fiber optic be manually moved between 
each of the 96 wells of the microfluidic device. Further, the PyroScience foil that is currently in 
use is opaque, making cellular imaging below the foil impossible. 
The goal of this project was to create an accurate high-throughput oxygen sensing system 
that maintains optical clarity for cellular imaging. The oxygen sensing system consisted of two 
major components, the optical platform and the sensing format. The optical platform is semi-
automated or high-throughput in terms of providing a continuous dissolved oxygen percentage 
feedback to a computer program. One major goal of this device over previous methods is the 
capability to run without user interaction after setup, thereby eliminating the necessity for 
researchers to be present during testing. The oxygen sensing format is optically clear, 
biocompatible, able to withstand a cellular environment for up to 14 days in culture, compatible 
with the optical platform, and able to survive the fabrication process of the microfluidic device. 
An appropriate format able to be quenched by oxygen was identified and a method of 
incorporating this format into the current device was implemented. As a final design, this format 
is optically clear, robust in that it can withstand normal device use, and able to produce accurate 
readings indicative of the oxygen percentage in the organ-on-a-chip device. Overall, this project 
set out to improve Draper’s current sensing system to more accurately represent in vivo 
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conditions by monitoring oxygen in cellular environments while maintaining optical access of 
the cells being studied via the use of custom fabricated and implemented oxygen sensing format. 
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CHAPTER 2: BACKGROUND 
 The environment in which a cell exists can influence over various cellular characteristics, 
such as proliferation and differentiation. Such environmental variability can come in the form of 
temperature fluctuations, salinity, or oxygen levels. To ensure that cellular studies are 
representative of in vivo characteristics, researchers must be able to accurately monitor and 
mimic the different factors of a natural cellular environment. 
2.1 Microfluidics 
To advance efforts in biomedical research, microfluidic systems are being used to create 
smaller scale multi-functional platforms that replace current macroscale assays [9]. This 
technology forms the basis for organ-on-a-chip devices, which are used to advance progress in 
clinical research and drug development efforts. Starting with processes of the 1950s aimed at 
generating integrated circuits rapidly and inexpensively, researchers have continuously strived 
towards creating high-speed, energy-efficient electronic systems at small-scales [10]. Combining 
these circuit studies with analytical chemistry techniques, particularly capillary electrophoresis 
as well as gas-phase and high-pressure liquid chromatography, scientists began to develop and 
rapidly expand a field known as microfluidics [11], [12]. Microfluidic devices manipulate small 
amounts of fluids, ranging from the attoliter to the microliter scale, using micron-scale channels. 
By applying fluid characteristics to small-scale devices, microfluidic technologies allow for 
precise control of concentrations of molecules in space and time [12]. Microfluidic technology 
has seen a significant expansion in recent years, with subsequent application in fields like 
chemical analysis and medical diagnostics. 
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Typically, microfluidic devices are utilized in bioanalytical and medical studies because 
their physical size provides advantages over normal lab-based devices [13]. Most of the societal 
need associated with organ-on-a-chip technology arises from the prospects of using these devices 
in both investigational research and in product development. For example, within the current 
drug development process, new medications have a success rate of approximately 8% of going 
from preclinical toxicology to market approval [14]. Microfluidics allows pharmacology 
researchers to mimic in vivo conditions inexpensively on the microscale, which allows for 
multiple replicates and less waste.  
Current organ-on-a-chip devices have shown the capability of mimicking the 
microarchitecture of organs. An example of this is from the Wyss Institute for Biologically 
Inspired Engineering at Harvard University, which has been able to simulate the functions of 
organs such as the lung, intestine, and kidney using organ-on-a-chip devices [15]. From this 
research, the Wyss Institute launched a startup company entitled Emulate, Inc., which aims to 
commercialize this technology in hopes of bettering standards of industrial development in the 
pharmaceutical industry and personalized medicine. In a recent study performed by the Wyss 
Institute, researchers were able to perform a toxicity study on primary human kidney proximal 
tubular epithelial cells [16]. Such work proves that microfluidic devices have the potential to 
recreate in vivo-like conditions that could serve as a tool for evaluating a wide array of 
physiological phenomena. Additional companies, such as Nortis Bio, are working to incorporate 
microfluidic devices into the existing biotechnology market as means of growing cells into three-
dimensional human tissues. Nortis uses a microfluidic chip with a custom perfusion platform to 
simulate human tissue microenvironments for vascular and organ-on-a-chip studies [17]. 
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2.2 Microfluidic Oxygen Sensing 
To aid in the successful use of microfluidic devices for clinical and medical research, 
there must be constant monitoring of the system state to ensure a standardized and regulated 
environment. Based on this need, research has shown that oxygen-sensing capabilities within 
microfluidic cell culture environments shows the capacity to quantify the behavior and viability 
of cell types as well as drug effectiveness [18]. Oxygen is a parameter of interest in cell culture, 
fermentation, and biocatalyst monitoring. Compared to pH, carbon dioxide, and glucose, oxygen 
is the most successfully implemented detection analyte in microfluidic applications. This is due 
to its ability to monitor cell metabolism via its simple sensing principle [6]. There are various 
sensing methods able to determine dissolved oxygen percentage including optical detection 
methods, Winkler titration, mechanical or pressure-based methods, and electrochemical methods 
[19]. 
Winkler titration is a titrimetric method of oxygen sensing which is commonly used in 
larger-scale dissolved oxygen monitoring, such as environmental applications. There are various 
types of Winkler titrations. The Azide-Winkler method is a commonly accepted, precise standard 
for dissolved oxygen sensing but has limitations that eliminate its feasibility for use in 
microfluidic environments [20]. Winkler titration cannot be modified for continuous oxygen 
sensing and samples must be taken from the device and contaminated with titrants [19]. This 
process is time consuming and it would not be ideal to integrate into a micro-sized system [20]. 
Electrochemical methods are more applicable to smaller volumes, like those 
characteristic of microfluidic devices, than the Winkler titration method. Figure 1A demonstrates 
the operating principle of the Clark electrode method. These systems consist of a silver anode 
and a platinum cathode, where oxygen is reduced. This generates a steady state current that can 
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be correlated to the percentage of dissolved oxygen in the solution [21]. Clark-electrode type 
sensors have been incorporated into microfluidic devices as illustrated in Figure 1B. This device 
consists of a miniaturized Clark-type electrode embedded below the microfluidic device. When 
potential is applied to the system, oxygen is reduced on the cathode and the change in current can 
be correlated to the dissolved oxygen percentage [22]. Clark electrode based systems are widely 
used but are not desirable for cellular based microfluidic systems because the electrode 
consumes oxygen and other gases can interfere with the sensing system [19]. 
 
 
Figure 1: A: Graphic indicating the components of a Clark electrode for sensing dissolved oxygen percentage. This 
image has been reproduced under the Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International 
License [23]. B: Miniaturized Clark-type electrode in a microfluidic application © Elsevier. Reproduced with 
Permission, Courtesy of Elsevier. See Appendix J: Copyright Approval [22].  
 
Pressure-based mechanical methods are not widely applied in oxygen sensing due to their 
invasive nature. Colorimetric oxygen sensing methods can also be used to detect dissolved 
oxygen levels but are not directly applicable to microfluidic devices. Indicators like indigo 
carmine and rhodazine D can be used in this method, but the indicators must be permanently 
added to the sample. This means that small volumes would need to be removed from the 
microfluidic device or the sample would be completely ruined. After adding the indicator, a 
measurement must be made in a short window of time [20]. Based on the drawbacks of these 
8 
 
methods, optical techniques have gained popularity and are the preferred method for microfluidic 
applications. This is because these principles do not consume oxygen, are completely reversible, 
maintain good precision and accuracy, operate non-invasively, can be easily miniaturized, and 
have a variety of sensor format options [19]. 
2.3 Optical Oxygen Sensing 
 The major principle behind optical oxygen sensing is luminescence quenching. 
Luminescence quenching is a reversible process that entails quenching of an excited medium. 
This medium can take a variety of forms like dyes or luminophores and excited energy is 
transferred to oxygen, rather than being emitted as light [24]. This results in an inverse 
relationship between the amount of dissolved oxygen and the emitted light. Figure 2 illustrates 
the luminescence quenching principle utilized in many optical based oxygen sensors. An 
excitation pulse of a known wavelength is supplied to the sensing medium and then a signal with 
a different wavelength is emitted from the sample proportional to the oxygen percentage present 
in the environment of interest. As illustrated in Figure 2, an important characteristic of this 
sensing principle is a Stokes shift between the emission wavelength and the excitation 
wavelength. In a general sense, it is ideal to maximize the Stokes shift to increase sensor 
accuracy and make it easier for the sensing component to distinguish emission light from 
background light [25]. 
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Figure 2: Illustration of the luminescence quenching principle used in many optical oxygen sensors. The sensor is 
able to measure the emission wavelength which can be correlated to the oxygen concentration present in solution. 
The difference in excitation and emission wavelength is referred to as the Stokes shift, with higher Stokes shifts 
having better sensor performance [25].  
 
Using luminescence quenching, oxygen can be detected via lifetime or intensity based 
measurements. Lifetime mechanisms can detect luminescence through either the frequency or the 
time domain in a reversible reaction with quenching molecules. In the time domain method, 
excitation pulses can be passed to the sample and emission intensity data is acquired at specified 
time points. Frequency domain based methods involve detecting phase differences. Both 
methods allow for the recording of the decay in signal after excitation, which is directly 
correlated to the amount of quencher molecule attached to the sensing format [24]. 
Overall, intensity based methods are simpler than lifetime based methods; however, they 
fall short in their susceptibility to leaching and photobleaching. Intensity-based sensing 
principles are typically improved by applying ratiometric sensing principles. This refers to when 
there is an oxygen sensitive medium and an oxygen insensitive medium. Both dyes will be 
excited by the same source and the ratio of emission intensities is calculated to determine oxygen 
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percentage. Overall, lifetime-based sensing principles are preferable to intensity-based methods 
due to superior contrast and elimination of confounding background noise [24]. 
When focusing on the reduction of fluorescence intensity, two different types of 
quenching processes are most often cited, collisional quenching and static quenching. Collisional 
quenching occurs when contact between an excited fluorophore and a molecule result in non-
radiative transitions to the ground state. Static quenching occurs when a fluorophore and a 
molecule form a complex that is non-fluorescent. There are many different equations that can be 
used to quantify fluorescence lifetime through quenching processes, such as the Stern-Volmer 
equation [26]. The Stern-Volmer equation relates observed emission intensities in the presence 
of quencher molecules to fluorescence lifetime. The Stern-Volmer equation is as follows: 
 
In this equation, I0 represents the rate of fluorescence when there is no quencher molecule 
present, IQ represents the rate of fluorescence in the presence of a quencher, kq is the Stern-
Volmer constant, τf is the lifetime of the emissive excited state of the chemical species of 
interest, and [Q] is the concentration of the quencher [27]. 
Furthermore, sensor formats, specifically some form of a reference indicator, must be 
considered when focusing on optical means of sensing oxygen. Some of the current formats 
utilized in research include luminescent dyes and nanoparticle-based systems [28]. One way to 
incorporate luminescent dyes is printing them directly onto a platform in which oxygen levels are 
of interest. Likewise, nanoparticles can be suspended within fluid systems where oxygen levels 
are being studied. Nanoparticle indicators can be delivered to these systems by either being 
encapsulated within polymer probes or being suspended directly in the fluid system. However, 
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when the nanoparticles are suspended directly in the fluid, there is a potential for phototoxicity. 
Additional sensor format possibilities include thin-film sensors attached to external substrates, 
optical fiber sensors, and water-soluble macromolecule probes [24]. 
2.4 Oxygen Quenchable Chemical Compounds 
 Various chemistries have been identified in literature as able to be quenched in the 
presence of molecular oxygen. This quenching process is a reversible process and does not result 
in consumption of the oxygen analyte. There is a wide range of optical luminescent indicators, 
which can be categorized as shown in Table 1 below. 
 
Table 1: Outline of the pros and cons of various indicators used for oxygen-based measurements 
Indicator Pros Cons 
Polycyclic 
Aromatic 
Hydrocarbons 
● Long excitation 
lifetimes and good 
pressure sensitivity 
● Non ideal excitation range: 300 
nm and 390 nm 
Polypyridyl 
Complexes 
● Wide range of 
absorption and emission 
wavelengths 
● Some of the most 
common oxygen 
indicators on the market 
● Short lifetime 
● Brightness 
● Subject to thermal quenching 
● Low accuracy in low oxygen 
● Cytotoxic effects over repeated 
excitation 
● Inefficient in their percent 
oxygen resolution 
● Difficult to suspend in PDMS 
Metalloporphyrins ● Strong phosphorescence 
and good molar 
absorption coefficients 
● N/A 
Cyclometalated 
Complexes 
● Large stoke shifts 
● Photostability  
● High luminescence 
quantum yields 
● Short decay times  
● Poor absorbance in the visible 
light region 
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The polycyclic aromatic hydrocarbons, PAH, are indicators that are characterized by long 
excited lifetimes and good pressure sensitivity. Some limitations of PAH-based sensors are 
centered around their lack of solubility in polymeric matrices and having a very small Stokes 
shift, which is defined as the apex of the absorption and emission spectra [29]. The excitation 
range of PAH indicators is between 300 and 390 nanometers which is not ideal due to 
background fluorescence that can interfere with readings at such small Stokes shifts. Due to 
these downsides, these indicators are rarely chosen over some of the following options [30]. 
 The second group of indicators are transition metal based polypyridyl indicators. Typical 
transition metals incorporated into these indicators include ruthenium and osmium. Depending 
on the exact composition, this group of indicators has a wide range of absorption and emission 
wavelengths. For instance, a Stokes shift of just under 400 nanometers is seen in the platinum 
based polypyridyl indicator, Pt(ddp)(CN)2. Most of these indicators, especially Ru(II)-based 
indicators, are excited through blue light. A disadvantage of these complexes is their 
characteristic short lifetime, brightness, their ability to be subject to thermal quenching, low 
accuracy in low oxygen settings, and cytotoxic effects over repeated excitation making these 
possibly hazardous for long term cellular testing. Additionally, while these are some of the most 
common oxygen indicators on the market, they are inefficient in their percent oxygen resolution 
and are difficult to suspend in polydimethylsiloxane (PDMS) and other oxygen permeable 
polymers. Overall, this makes using these indicators very difficult for large scale testing and 
prototyping.  
Metalloporphyrins are very commonly used as optical oxygen sensors, specifically due to 
their large Stokes shifts, strong phosphorescence, and good molar absorption coefficients. The 
indicators in this class incorporate both Pt(II) and Pd(II) porphyrins. A major advantage of these 
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indicators is their ability to be excited by red light with an emission in the NIR range allowing 
for distinguished input and output signals indicated by a large Stokes shift. Indicators with these 
capabilities are often preferred due to good performance in scattering media and reading low 
oxygen levels while also having the ability to incorporate cheaper sensing components, than blue 
light excitable indicators. 
Cyclometallated complexes are also used for optical oxygen sensing. Advantages of this 
class of indicators include large Stokes shifts, photostability, and high luminescence quantum 
yields. Negatives of these indicators are centered around poor absorbance in the visible light 
region as well as short decay times. There are also various other classes of oxygen quenchable 
indicators with differing central atoms. Important factors that must be considered when selecting 
an oxygen quenchable indicator include toxicity to the environment of interest and the 
fabrication of the indicator [30]. 
2.5 Examples of Current Optical Oxygen Sensors  
 Current optical oxygen sensors used in industry and research include the Agilent 
Seahorse, the PyroScience Piccolo2 and FirestingO2, the PreSens Duo1, and the PreSens SDR 
SensorDish. 
2.5.1 Agilent Seahorse 
 The Seahorse is an incubation system that invasively measures dissolved oxygen and pH 
in cell culture media in a 96-well plate, as seen in Figure 3 and Figure 4 [31], [32]. This device 
gives accurate readings efficiently in real-time. However, it is large and there is a possibly of 
disturbing the cells in the media. 
 
14 
 
 
Figure 3: This diagram illustrates the operating principles behind Aligent’s Seahorse XF Analyzer. This device is 
able to monitor dissolved oxygen and pH, but the sensors are in direct contact with the cellular environment. This 
image has been reproduced under the terms of the Creative Commons Attribution License [31]. 
 
 
Figure 4: The Seahorse XFe96 Analyzer used to measure oxygen consumption rate and extracellular acidification 
rate in cellular samples in a 96-well format. This device is compact and able to fit on a laboratory benchtop [32]. © 
Agilent Technologies, Inc. Reproduced with Permission, Courtesy of Agilent Technologies, Inc. See Appendix J: 
Copyright Approval. 
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2.5.2 PyroScience Piccolo2 and FirestingO2 
 The Piccolo2 and FirestingO2 are both made by PyroScience and utilize red flash 
technology to determine the oxygen percentage non-invasively and in real-time using a sensor 
format. There is no oxygen consumption due to the optical format, but the device is hard to work 
with and requires extensive manual labor to move from channel to channel in a 96-well device. 
The Piccolo2 can be seen in Figure 5 and has a fiber optic cable that is inserted into the device 
and produces a red flash on a sensor format to obtain oxygen percentage readings [33]. The 
Piccolo2 solely measures oxygen percentage, which is greatly affected by temperature variations 
requiring the system to be used in a temperature controlled environment. On the other hand, the 
FirestingO2 has the capability of incorporating four oxygen sensors and a temperature sensor. 
Figure 6 illustrates the FirestingO2 with the leftmost port being a temperature port and the 
remaining four ports allowing for attachment of a fiber optic cable for oxygen sensing [34]. 
 
 
Figure 5: Piccolo2 device for measurement of oxygen concentration in solution. One end of the device serves as a 
USB connection, while the other end allows for attachment of a fiber optic cable to transmit excitation light and 
receive emitted light from the sample. All data gathered during use of this device is collected and processed through 
a custom program created by PyroScience [35]. © PyroScience GmbH. Reproduced with Permission, Courtesy of 
PyroScience GmbH. See Appendix J: Copyright Approval. 
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Figure 6: FirestingO2 device for measurement of oxygen concentration in solution with built in temperature control. 
This device is essentially four Piccolo2 devices in one with the addition of a temperature probe to reduce errors due 
to temperature sensitivity [34]. © PyroScience GmbH. Reproduced with Permission, Courtesy of PyroScience 
GmbH. See Appendix J: Copyright Approval. 
2.5.3 PreSens Duo1 
 The Duo1, pictured in Figure 7, is similar to the Piccolo2 and FirestingO2, but uses blue 
flash technology. It non-invasively monitors oxygen in real time using a sensor format without 
any oxygen consumption. However, the sensor is too large to read the small wells in a 96-well 
plate accurately. The Duo1 also has an incorporated camera that records the oxygen levels and 
displays them to the user in a visual color-coded map [35]. 
 
 
Figure 7: Duo1 device and sensing format for determining oxygen concentration in solution. This device operates 
using blue flash technology [35]. © PreSens Precision Sensing. Reproduced with Permission, Courtesy of PreSens 
Precision Sensing. See Appendix J: Copyright Approval. 
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2.5.4 PreSens SDR SensorDish 
 The PreSens SDR Sensor Dish is a high-throughput detection device with the capability 
to sense both pH and oxygen in a non-invasive manner. As illustrated in Figure 8B, the device is 
a plate that has 24 different integrated pH and oxygen sensors [36]. When using this device, well 
plates with a sensor spot in the bottom of each well must be used. The well plate is placed on the 
sensor dish such that the sensor spots are directly over the sensors as illustrated in Figure 8A 
[36]. To obtain accurate analyte readings, this device must be operated in a dark area such as an 
incubator. Additionally, this system can work in parallel with its duplicates, seen in Figure 8C, in 
turn reducing the number of output cables to one instead of having one for each system. One 
drawback of this device is that the sensor dish is only made for custom twenty-four or six well 
plates and requires the purchase of PreSens’s custom well plate. 
 
 
 
Figure 8: SensorDish device capable of simultaneously reading oxygen concentration in real-time in a custom 24-
well plate. The plate to be tested sits on top of the excitation source; this device can also be operated in an incubator 
as illustrated in picture C above [36]. © John Wiley and Sons. Reproduced with Permission, Courtesy of John Wiley 
and Sons. See Appendix J: Copyright Approval. 
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2.6 Current System at Draper 
Organ-on-a-chip technology has been a central focus of Draper’s biomedical research 
department over the past 15 years. The device Draper is currently testing started as a single 
channel structure and evolved to a device with one column of eight separate channels. Now, 
Draper is working on a device consisting of 96 separate channels. Each step in this iterative 
process has consisted of validation and testing to ensure that the fabrication process, device 
materials, biocompatibility, channel structure, and bonding method support the device as it 
advances towards its final goal: mass development for drug testing. 
 The 96-well design has the same dimensions of common 96-well plate formats found in 
most laboratories as dictated by ANSI standards. This form makes the device more marketable to 
the general research community while providing 96 replicates for maximum drug studies. While 
Draper’s device follows the format of a 96-well plate, it is not an addition to pre-existing 96-well 
devices; instead, it acts as its own system. Additionally, instead of wells, each of these 96 
sections is occupied by a microfluidic construct that allows for the containment and culture of 
human or animal organ cells. Each channel is composed of a top and bottom segment separated 
by a semipermeable membrane and has two inlets and two outlets. The final version of this 96 
well plate design consists of 384 separate reservoirs on the top of the device to separate the inlets 
and outlets. This top component integrates with a pumping system supplying the bottom channel 
with a supply of new media. A full depiction of the current device can be seen in Figure 9. 
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Figure 9: A graphic depicting a side view and top view of Draper’s current microfluidic device. The device consists 
of two channels separated by a semipermeable membrane that allows for the diffusion of oxygen and nutrients 
between the channels. Cells are seeded in the top channel of the device via an inlet port. Oxygen concentration is 
currently sensed in this system through use of the Piccolo2 sensor and a corresponding sensor foil as illustrated in the 
image above. The sensor foil inhibits the optical path in the area below the foil, as illustrated by the dotted region in 
the figure above. 
  
The purpose of the semi-permeable membrane between the channels is to allow cells to 
be seeded in one of the chambers through the inlet port while permitting the bottom channel to 
be perfused continuously with fresh media. This bilayer format allows for the ability to co-
culture epithelial and endothelial cells. The semi-permeable membrane prevents flow from 
dislodging the cells after seeding, while allowing the proper nutrients and oxygen to pass through 
to help maintain cell viability. Previous attempts to integrate oxygen sensing into this device 
utilized the removable fiber optic cable from PyroScience’s Piccolo2. The top layer has a specific 
cut out for the fiber optic to get as close as possible to an oxygen sensitive foil material, 
represented by the green and black rectangle in the top channel. A thin transparent film of cyclic 
olefin copolymer, otherwise referred to as COC, between the fiber optic and foil ensures that the 
channel is still a closed system, while limiting the amount of COC that separates the two. 
Currently the foil is 50 µm in height, which requires an extra step in the fabrication process to 
create a recess to place the foil into the channel without it obscuring flow. A downside of this 
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system is that it requires the single Piccolo2 to be manually moved between each of the 96 wells 
of the microfluidic device.  
Overall, Draper is interested in the development of an oxygen sensing system that can be 
added to their final product for multiple reasons. Since the final product’s purpose is to enable 
drug testing using human organ cells, it is imperative to monitor cell viability before, during, and 
after testing. Oxygen sensors have proven to be an effective medium to achieve this task in real 
time. Moreover, Draper has previously explored the possibilities of monitoring both pH and 
glucose levels in their organ-on-a-chip device and the addition of an oxygen sensor will improve 
the functionality and marketability of their final product. Another inherent benefit of integrating 
an oxygen sensor is the ability to monitor oxygen in the environment where the device is being 
tested. Many incubators, when operating at hyperoxic levels, pump in oxygen to maintain 
specific environmental levels at preset rates, which can be expensive. Alternatively, an oxygen 
sensor can be used to ensure new media is only added when oxygen percentage is too low. In 
some cases the desired oxygen level may be different from what the incubator is set at, leading to 
the overuse of oxygen or compromised data from inaccurate oxygen levels. In addition, 
recording oxygen levels in these environments allows for metabolic profiling capabilities, 
particularly when pH is monitored in conjunction.  
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CHAPTER 3: METHODOLOGY 
3.1 Initial Client Statement  
Our team worked with Draper to aid in the design and implementation of a system for 
real-time oxygen measurements within organ-on-a-chip systems. The existing system is a high-
throughput, microfluidic tissue culture platform capable of generating and sustaining 
physiologically relevant multicellular culture environments. Ideally, the results of this project 
should allow oxygen levels to be easily measured in Draper’s platform without impeding the 
current capabilities of the device. Furthermore, this system must be validated through detailed 
procedures involving both solutions of known oxygen percentages. 
3.2 Objectives 
The team determined the design objectives seen in Figure 10 based on the client’s needs 
and the information from background research. The final design should be biocompatible, 
optically clear, accurate, stable and adaptable, acquire data over extended periods, acquire data in 
an automated fashion, compatible with the current device fabrication process, and able to 
integrate within the current system in a high-throughput manner. 
 
22 
 
 
Figure 10: Design objectives. Within the central circle, the overarching goal of the project is shown. Each 
surrounding circle represents an objective of the solution that is ideal to assure project success. 
3.2.1 Biocompatible and Bioinert 
 The team’s addition to the current system should not affect cellular viability during 
normal device operation. Additionally, the oxygen indicator and incorporation method utilized 
within this system should not affect cellular function or phenotype throughout the testing 
process. To prove that cellular viability, function, and phenotype are not impeded or altered 
during the entire span of device utilization, all systems must be tested and compared to baseline 
data collected using the system currently employed by Draper. This comparison will allow the 
biocompatibility of the device to be evaluated. 
3.2.2 Optical Clarity 
 The sensor format that the team pursues should allow for cells in the 96-well plate to be 
imaged by microscopy. Therefore, the sensor format that is selected and its associated 
incorporation method must be optically clear or out of the optical path, which is defined as the 
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channel in which tissue and cellular cultures are seeded. As defined by the clients, optical clarity 
can be determined through visual analysis. This means that the optical clarity of the system is 
sufficient if the cellular structures tested within the device can be identified and imaged. 
3.2.3 Accuracy 
 The final device must provide accurate oxygen percentage data. Based on the 
PyroScience Piccolo2 currently used at Draper, this is defined as a signal intensity greater than 50 
mV [33]. Prior to each study, the Piccolo2 must be calibrated using known oxygen standards to 
account for any drift in accuracy. The method of calibration depends on the sensor format being 
used; for example, the system has separate calibration codes specific to the sensor format that 
must be inputted into the PyroScience data acquisition software. Most importantly, the indicator 
cannot consume any oxygen because this could impede cell growth and would not reflect correct 
oxygen levels of the media. 
3.2.4 Adaptable and Stable 
The selected indicator should be adaptable, as it is meant to be used for drug research, 
which requires varying conditions in accordance with the type of test. For example, the sensor 
format must be able to work under multiple sampling rates, meaning that it must have a 
sufficient response time to match testing conditions. Additionally, the format should be able to 
withstand the environment produced during device testing and employment. This means the 
indicator must be able to work in standard cell culture environments with a range of parameters 
such as pH and salinity. Furthermore, the sensor format must be able to withstand temperature 
fluctuations to accommodate possible testing conditions used in drug development.  
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3.2.5 Extended Time 
The sensor format that is selected must be able to undergo constant use for periods of up 
to 14 days. This means that there should not be variability in data readings at the points of 
primary and final testing. 
3.2.6 Automated Acquisition 
 The indicator should be located within the channel to allow for high-precision signal 
acquisition. The location of the sensor format must ensure that optical sources of excitation and 
emission readings are able to reach the sensor without any user input. For example, the final 
device should not require the user to move the sensor across the channel to obtain oxygen 
percentage readings at desired points. 
3.2.7 High-Throughput Integration 
The sensor format should be able to be incorporated into the existing platform in a high-
throughput manner. For example, the end user can integrate the sensor format using a multi-
channel pipette or a robotic liquid handler. Similarly, the sensor format can be incorporated into 
the final system during the manufacturing of the plate. 
3.2.8 Pairwise Comparison  
The team ranked the objectives described above using a pairwise comparison chart, as 
seen in Table 2. A pairwise comparison chart determines the importance of design objectives by 
listing the objectives across the first row and down the first column of a table. Then the objective 
in the column is compared against the objective in the top row. A ‘1’ in the table indicates that 
the objective in the column is more important than the one in the row, a ‘0.5’ means that the two 
25 
 
objectives are of equal importance, and a ‘0’ means that the objective in the column is less 
important than the one in the row. The total in the final column is the sum across the table, which 
indicates the weight of each objective. The project sponsor and team found the order of 
importance, ranging from most important to least important to be biocompatible and bioinert, 
accuracy, adaptable and stable, automated acquisition, extended time, high-throughput 
integration, and optical clarity. Since cells are used during device use, the clients determined that 
the biocompatibility of the indicator must take precedence over other objectives. This project is 
primarily concerned with the ability to measure accurate oxygen levels within microfluidic 
devices, which results in this objective being ranked second. Although optical clarity optical 
clarity was ranked as a ‘0’ for the total score, it does not mean that it was not considered when 
the team evaluated each sensor format. This ranking means that optical clarity of the sensor 
format is not imperative for the system to function on a base level. For comparison, if the format 
was not biocompatible and toxic to cells the organ-on-a-chip device would not be functional; 
however, even if optical clarity was impeded the device could still be used.  
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Table 2: A pairwise comparison chart using the team’s design objectives. Each objective is ranked comparatively to 
the other objectives. This allows the team to derive which objective is considered the most important with respect to 
the final outcome. 
 
3.3 Design Constraints and Specifications 
 Based on input from Draper and background research, the team determined design 
constraints of patterning, functionality, robustness, morphology and imaging, biocompatibility, 
and project budget and timeline. Design constraints refer to parameters that must be met for the 
system to be functional. Each constraint is paired with associated quantitative specifications as 
illustrated in Table 3. 
 
Table 3: Design constraints (left) and specifications (right). Each constraint is considered essential for project 
success. The specifications further quantify the constraints of the project to better define the requirements that 
characterize the constraints as being met or unmet. 
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3.3.1 Patterning 
For the sensor format to be compatible with the channel size used in Draper’s device, the 
diameter of the sensor format must be between 300 μm and 800 μm. Additionally, the means of 
patterning the sensor format onto the device must have a 100 μm tolerance in terms of both 
format positioning and size of the drops due to the channel size of the current device.  
3.3.2 Functionality 
In terms of functionality, the sensor format must be able to adhere to the COC substrate 
such that it does not wash off when subjected to the various flow conditions used during device 
operation. The sensor format must also yield an adequate signal intensity reading from the 
optical platform when the excitation source is placed a maximum of 1 mm away from the sensor 
format. Signal intensity refers to an output of the current optical platform, which relates to the 
accuracy of the readings. Higher signal intensities correspond to more accurate data and lower 
signal intensities mean that the output data is less likely to be representative of true parameters. 
The current optical platform cites that a signal intensity greater than 50 mV is required for 
sufficient data acquisition [33]. Additionally, the sensor format height should not exceed 10 μm 
since this would interfere with device operation by obstructing flow.  
3.3.3 Robustness 
Robustness refers to the ability of the sensor format to maintain integrity after being 
exposed to various parameters common during device operation. The sensor format must be able 
to withstand typical cell culture conditions of an incubated environment. This means the device 
must be able to operate within specified temperature and humidity ranges characteristic of 
common incubation units. The format should maintain functionality after 7 to 14 days submerged 
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in cell culture media in a 5% CO2 and 37°C environment. Based on current device fabrication 
parameters used at Draper, the sensor format must be able to withstand exposure to a temperature 
of 120°C for one hour, a total force of 18,000 pounds for 15 minutes, a force of 3,700 pounds for 
40 minutes, and EtO sterilization parameters. 
3.3.4 Morphology and Imaging 
 To monitor cells in the final device during testing, the sensor format must be able to be 
imaged through. When imaging through the sensor format, the true cell morphology must not be 
altered or obstructed by the sensor format in any way.  
3.3.5 Biocompatibility 
The sensor format must not interfere with any features of the cellular environment 
including cell viability, cell functions, and phenotype. 
3.3.6 Project Budget and Timeline 
The project must be completed by May of 2018. The final device should be identified and 
prototyped for a cost of no more than $2,000 spent during the development process. A 
prototyping cost breakdown is detailed in Section 3.7.1 Financial Approach. 
3.4 Sensor Format Functions and Functional Blocks  
After developing the objectives and design constraints, the necessary functions of the 
device were established as illustrated in Figure 11. 
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Figure 11: Functions necessary to create an improved oxygen sensing system. These functions must be 
accomplished by any of the selected sensor designs and their associated formats. By accomplishing all of the 
functions, the oxygen sensing system is assured to work within the existing microfluidic device. 
 
The sensor format that is created must be able to integrate into the current organ-on-a-
chip system in a high-throughput manner. The chosen sensor format must also be able to quench 
oxygen in response to visible light excitation and provide accurate readings with the optics 
platform at Draper. This platform will allow for the wavelength of the excitation light to be 
modified depending on the properties of the sensor format that is being used. However, this 
sensor format must have the correct chemistry to be able to quench oxygen in response to a 
specific excitation frequency. The sensor format also must have a high enough Stokes shift for 
the emission light to be differentiated by the optics platform. Lastly, the format must function for 
a two week time period and not degrade in exposure to cell media or visible light excitation. 
3.5 Design Standards  
Standards specific to microfluidic platforms have begun to emerge as these devices are 
becoming increasingly prevalent in industry, as seen in Figure 12. 
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Figure 12: This figure displays the standards that the final device must follow. The device must abide by these 
standards, established by a variety of organizations, during the fabrication process. This process includes 
incorporation of the oxygen sensing system. 
 
The National Institute of Standards and Technology, NIST, has various categories of 
standards that must be considered during the design of microfluidic devices. Specifically of 
interest to this project, the NIST recognizes the importance of obtaining accurate, reproducible, 
and appropriately sensitive optical measurements [37]. Few standards have been adopted by the 
microfluidics industry and individuals have identified a need for comprehensive standards to be 
adhered to throughout the field [38]. The Semiconductor Equipment and Material International, 
SEMI, organization has a standards program and have specifically created two major standards 
for microfluidics. MS6-0308 is a standard created by SEMI that outlines proper material 
selection for devices and design parameters that should be considered when creating a device. 
This standard is directly applicable to design of microfluidic devices and will be useful in 
selecting appropriate sensor format materials to add to the device. Secondly, MS7-0708 is 
applicable to this project as it has guidelines for how electronics should properly interface with 
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microfluidic devices, which should be considered because of integration of an optics platform 
with the device [39]. 
The International Organization for Standardization, ISO, also has two standards that are 
applicable to this project in terms of using an optical sensor and classifying microfluidic devices. 
ISO 17289:2014 outlines guidelines for determining dissolved oxygen content in water. Since 
our system determined dissolved oxygen content in cell media, this is not directly applicable but 
content in this standard will serve as a valuable reference [40]. Secondly, IWA 23:2016 contains 
guidelines for pitch spacing and microfluidic device classification. Although this is more 
applicable to the existing device than the sensing mechanism, it will be important to understand 
this standard to ensure the system does not violate any guidelines for proper classification [41]. 
The device created in this project is meant to be incorporated in a general microfluidic 
testing platform that can be used for drug discovery. Given this application, the device is not able 
to be classified as a medical device and would not be subjected to FDA standards in regards to 
medical devices. However, the FDA does have standards that outline the drug development 
process that must be considered during design if the device is intended to be used for drug 
discovery. The FDA splits the drug development process into five different stages with step two 
dealing with preclinical research and being the most applicable to organ-on-a-chip devices. This 
phase requires that researchers use good laboratory practices, also known as GLP, when testing 
drugs both in vivo and in vitro. The FDA regulations in regards to GLP that should be followed 
can be found in 21 CFR Part 58.1: Good Laboratory Practice for Nonclinical Laboratory Studies 
[42]. These standards must be known during the design process to prevent any complications in 
compliance when the product is complete. 
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3.6 Revised Client Statement 
As stated in the original client statement, one of the major goals of this project is to 
improve the current method for acquiring oxygen percentage data from Draper’s 96-well organ-
on-a-chip device. This statement is broad to prevent any restrictions on the process of ideation, in 
turn allowing for exploration into a variety of solutions. Since the initial statement, the project 
has gained more dimensions and structure based off research and early design ideas. 
According to the revised client statement, the scope of this project is to improve the 
current standard of oxygen sensing in Draper’s organ-on-a-chip devices. The client wanted the 
team to identify possible indicators compatible with an optical platform and determine a means 
of incorporating this indicator into the existing device. The indicator must not compromise the 
usability of the current device. 
3.7 Management Approach 
 To achieve all of the tasks outlined within the scope of this project, multiple 
organizational strategies were developed and are described in the following sections. 
3.7.1 Financial Approach 
Ultimately, this project should result in a completed oxygen sensing system by May of 
2018. The entirety of this project must be completed within the given $4,000 budget. This budget 
has been subdivided such that 50% of all funds are allocated towards device research and 
development while 50% is allocated to travel costs, as per client request. As seen in the 
following pie graphs, displayed in Figure 13A, the design budget was subdivided into three main 
phases: the research phase, the prototyping phase, and the final design phase. These phases were 
allocated 5%, 15%, and 80% of the design budget, respectively. The final design budget was 
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then further divided to include budgeting towards the indicator format, means of incorporating 
the indicator within the microfluidic device, and additional hardware utilized throughout the 
production process; this division can be seen in Figure 13B. The majority of money is allocated 
to indicator format purchases since many luminescence quenching dyes and nanoparticles cost 
greater than $100 for only a gram of material. For example, the PyroScience nanoparticles cost 
upwards of $292.00 for 10 mg of raw nanoparticles, where eight 3 cm2 pieces of foil material 
from PyroScience cost $280. Secondly, the indicator incorporation budget is also substantial due 
to the cost of adhesives such as PDMS or other biocompatible epoxies. 
 
 
Figure 13: A: The estimated budget for the total scope of the project. This includes the three main phases of the 
project: the research phase, the prototyping phase, and the fabrication phase. B: The estimated budget for final 
device design, fabrication, and testing. The final device budget includes separate components for determining the 
sensor format and for determining the means of incorporating the selected format within the final device. 
3.7.2 Work Breakdown 
To reach this end goal, the entirety of this project has been divided into three main phases 
classified by their staggered completion goals throughout the 2017-2018 academic year. Initially, 
during phase one of this project, user requirements will be solidified. These requirements will 
then be analyzed to determine their total contribution to the client-defined requirements and 
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subsequent conceptual designs will be generated. In phase two of this project, proof of concept 
prototypes will be created to demonstrate the varying levels of design feasibility. The third phase 
of this project includes the construction and validation of a final system in accordance with 
methods and techniques mentioned in the client statement. To ensure the project is completed in 
a timely manner, each phase of the project has been subdivided into required tasks, which are 
included on the Gantt chart in Appendix A: Gantt Chart. To further classify the subdivisions of 
work that are detailed within the provided Gantt chart, the team generated a work breakdown 
chart shown in Appendix B: Work Breakdown Chart to ensure thorough understanding of the 
project scope.  
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CHAPTER 4: DESIGN PROCESS 
4.1 Conceptual Designs 
 After determining the priority of the objectives, design constraints, and functions, 
conceptual designs were brainstormed. Two major project components were identified that are 
required for a fully functional system as illustrated in Figure 14. These components include the 
optical platform and the sensor format. In terms of the sensor format, the team considered both 
the fabrication method and how the format will be implemented into Draper’s existing device. 
The optical platform refers to the means of providing visible light excitation to a sensor format in 
the organ-on-a-chip device in a high-throughput manner that does not require user input. 
Secondly, the format of the oxygen quenchable sensing material was evaluated. After deciding 
on a sensor format, the team considered how to fabricate the sensor format into something that 
could be implemented into the existing device. Lastly, the procedure for implementing the sensor 
format into the device was determined. 
 
 
Figure 14: A breakdown chart of the project components and subcomponents. The sensor format, being the major 
component of interest to this team, is further broken down to fabrication and implementation components to better 
exemplify the different aspects that must be considered for project success.  
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Six different conceptual ideas were identified for the optical platform as illustrated in 
Figure 15.  
 
 
Figure 15: Conceptual designs for the optical platform. These different optical platforms operate under the same 
principle of sensing oxygen through optical technology. In the top left, an array of LEDs would provide excitation 
and emission readings to each of the 96 channels simultaneously. In the top right, an angled mirror would direct the 
excitation and emission signals to each of the channels in the device, moving the optical pathway to each channel. 
The two middle designs involve triaxial movement; the one on the left moves the sensor while the idea shown on the 
right moves the plate. The bottom left involves multiple fiber optic cables attached to a single sensor; each cable 
accesses one of the channels within the device. The bottom right corner depicts a method of sampling the media and 
taking oxygen readings of the sample using a standard oxygen measurement device.  
 
The first concept was an array of 96 LEDs and photodiodes that would be matched to the 
excitation wavelength of the chosen sensor format. This method would completely replace the 
Piccolo2 and could result in decreased accuracy. Secondly, a device in which a light source is 
shined on a mirror that could be angled to each well to excite the dye was created. The next two 
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conceptual designs incorporate the existing PyroScience sensor, but in a high-throughput 
manner. In one iteration, a fiber optic holder, able to be moved in the x, y, and z-axes, using 
three different stepper motors would move the cable to get a reading from each channel. In a 
similar sense, the optical platform could be held stationary and the organ-on-a-chip device could 
be moved in a triaxial manner to align each well for taking a reading. The next concept uses a 
split fiber optic cable such that there is one fiber for each channel in the device. This would be 
incorporated into a optical platform that the organ-on-a-chip device can sit on top of while 
simultaneously acquiring readings from all channels. Lastly, the team identified that media could 
be sampled from each channel and tested using Raman spectrometry. However, this method is 
not feasible as it contaminates the cellular environment and is more time consuming than the 
current method used by Draper. Based on these preliminary concepts, Draper decided to move 
forward with creating an array of 96 LED sensors, as illustrated in Figure 16 while the team 
focused on the associated format and the corresponding fabrication and implementation methods. 
 
 
Figure 16: One-row cross section of the optical platform designed by Draper. This device consists of a 96 LED 
sensors able to excite a sensor format in each microfluidic channel to obtain real-time oxygen concentration 
measurements in each channel. 
 
Three sensor formats for incorporating the oxygen quenchable dye were identified based 
on their compatibility with the current system as illustrated in Figure 17. The first possibility 
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uses a raw dye solution, which can either be purchased from a vendor or synthesized in a lab. 
Alternatively, the same chemical that is in the dye is commercially available through vendors, 
like PyroScience, in different forms including foils and nanoparticles. The foils come in small 
sheets in which different shapes can be punched out and incorporated into the existing device. In 
contrast, the nanoparticles can be suspended in solution and put into a matrix or directly injected 
into the culture media. All of the sensor formats pursued operate using the principle of 
fluorescence quenching in the lifetime domain. 
 
 
Figure 17: A diagram of three possible sensing formats that incorporate the oxygen quenchable dye. The top left 
shows a dye-based solution that incorporates the oxygen-sensitive chemical. This same chemical is used in the 
sensing foil, shown in the top right, and the nanoparticle-based indicator, shown in the bottom. 
 
After determining the possible sensor formats, fabrication methods were brainstormed, as 
seen in Table 4. One option would be that the nanoparticles could be suspended in a solution like 
DI water or a detergent. Additionally, the sensor format could be placed in a matrix like PDMS 
through various means. One example would be a PDMS stamp with nanoparticles acting as the 
ink. Furthermore, the nanoparticles could be mixed with PDMS prior to polymerization.  
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Table 4: Table of the different fabrication methods explored during this project. Each fabrication method is 
displayed in the left column. The different sensor formats to which these methods are applicable are shown in the 
right column. 
 
 
 After considering the excitation methods, the team considered sensor formats, fabrication 
methods, and concepts for implementing the format into the existing device, as seen in Table 5. 
The first concept explored used PDMS to adhere the fabricated sensor format into each channel. 
Alternatively, another adhesive like epoxy could be used in a similar fashion. However, it was 
uncertain if epoxy will react with the chemical dye and render it unreliable. Additionally, if the 
sensor format is fabricated in a solution it could be injected into the inlet port of each channel. 
The sensor format could also be patterned onto the COC prior to bonding and dried onto the 
surface as a film. The final possibility involved depositing a uniform layer of the indicator on the 
COC and processing the sample using a Carver press. A Carver press simultaneously heats and 
applies pressure to a material that is placed between its platens. The team hypothesized that 
heating the material just under the glass transition temperature would cause the sensor format to 
be pressed into the COC due to softening at elevated temperatures. 
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Table 5: Table of the different format implementation methods explored during this project. In the left column, a 
general name that represents each of the implementation methods is displayed; in the right column, these methods 
are explained in further detail. 
 
4.2 Alternative Designs and Feasibility Testing 
 The team then identified alternative designs to pursue in terms of implementing sensor 
formats and their fabrication. The alternative designs selected are illustrated in Figure 18 and 
will be elaborated on in this section. 
 
 
Figure 18: Alternative designs to pursue in terms of implementing sensor formats and their fabrication. Each of the 
blocks in this figure represent a combination of the different format and fabrication methods. The implementation 
component of this project is not included in this diagram. 
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4.2.1 Foil Testing 
 Testing was performed with the foil material that is used in the current system at Draper, 
to determine if altering foil geometry was a feasible solution to the optical clarity objective. A 
solid circle and a ring of foil material were bonded to a polystyrene well plate using PDMS, as 
illustrated in Figure 19. To gauge the optical clarity of these of formats, they were each imaged 
at 4X magnification as illustrated in Figure 20. Despite having better clarity, due to the open 
center, the ring was concluded to not provide sufficient optical clarity. 
 
 
Figure 19: Preliminary foil testing with solid foil and ring foil, foils were bonded to polystyrene well plate using 
PDMS. The foils were cut using standard biopsy punches and then set in the PDMS. The PDMS was allowed to cure 
for 48 hours at room temperature. 
 
 
Figure 20: Optical impedance of a 1 mm diameter foil under 4X magnification. The black spots indicate the location 
of the foil within the well. This representatively shows the significant optical impedance of the microfluidic channel 
generated through the use of the foils.  
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 In addition to optical clarity tests, the signal intensity measured with each foil geometry 
was recorded as illustrated in Table 6. These tests concluded that the ring foil would not provide 
sufficient signal intensity unless the Piccolo2 was moved to the border of the foil. This would not 
improve upon Draper’s current system and therefore was not considered for further evaluation. 
Further testing could be run to determine the minimum foil size necessary to obtain adequate 
signal intensity; however, this would mean that there would still be a portion of the channel that 
is not optically clear which does not meet the project objectives. 
 
Table 6: Piccolo2 signal intensities corresponding to a solid foil, the center of a foil ring, and the edge of a foil ring. 
The fiber optic cable of the Piccolo2 was held flush to a polystyrene well plate, corresponding to a distance of 1.8 
mm away from the foil. 
Foil Geometry Signal Intensity (mV) 
Solid foil  89.09  
Center of ring of foil  39.44 
Edge of foil ring  81.99 
 
4.2.2 PyroScience Dye 
The team also pursued using a dye-based form of the indicator solution, which was the 
raw form of the nanoparticles. The dye comes in both hydrophilic and hydrophobic forms; 
fabrication instructions of both forms of this dye can be found in Appendix C: Dye. Appendix C 
highlights the effects of the chemicals, which are used in the creation of the two dye forms, on 
COC. This serves as means of validating the compatibility of these chemicals in reference to the 
final device. To explore the concentration of the indicator in the dye, the team analyzed droplets 
of the hydrophilic dye suspension via microscopy, shown in Figure 21. Initial visual inspection 
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indicated that the dye is highly concentrated; despite this, initial testing using the Piccolo2 system 
resulted in a signal intensity in the 128 mV range, which was much lower than expected.  
 
  
Figure 21: Droplet of the hydrophilic dye suspension under 10X magnification. As shown, the dye is extremely 
concentrated and, thus, causes significant impedance of the optical pathway of the device. 
  
As shown in the above figure, the hydrophilic dye suspension resulted in an opaque layer 
across the surface of the COC. To determine the topography of the dye layer, the team imaged 
the center of the droplet under a laser confocal microscope at 20X magnification, the results of 
which are displayed in Figure 22 below. As shown, there was significant variation in the height 
across the surface of the COC after the dye dries. This was most likely because the hydrophilic 
form of the dye exists as a suspension rather than a homogeneous solution and contains particles 
of significant size that affect the overall surface topography. 
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Figure 22: Laser confocal analysis at 20X magnification of a hydrophilic dye solution droplet dried on a piece of 
COC. This figure shows the rough surface topography of the dye when placed on COC and shows the prominent 
height of the dye solution. Being that the dye solution is nearly 50 microns in height, there would be flow impedance 
within the microfluidic channel. 
4.2.3 Nanoparticles 
 To determine the best method for incorporating nanoparticles into Draper’s device, the 
team explored various preparation methods using nanoparticles. The team first looked at 
suspending nanoparticles in solution, then nanoparticles mixed in PDMS, PDMS stamping of 
nanoparticles, and a dried film of nanoparticles.  
4.2.3.1 Nanoparticles in Solution 
 The team performed additional testing with nanoparticles mixed with a 21% oxygen DI 
water solution. 2 mL of nanoparticle stock solution at a concentration of 5 mg/mL was created 
by adding 2 mL of deionized water to the dry stock of nanoparticles. Team members created 
dilutions from 5 mg/mL to 0.5 mg/mL, decreasing in 0.5 mg/mL increments, with two replicates 
for each concentration. A concentration of 0.1 mg/mL was also prepared since this is the 
minimum concentration recommended by PyroScience. The setup for the dilution well plate can 
be seen in Figure 23. Throughout this testing, all data was analyzed using a MATLAB program 
the team developed which can be found in Appendix D: MATLAB Code for Piccolo2 Data 
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Analysis. This testing illustrated the immense difficulties with creating a homogeneous 
distribution of nanoparticles on the bottom of a hydrophilic surface. Not only did the 
nanoparticles noticeably settle in less than two minutes, but also they visibly clumped to the 
center of the well. Additionally, higher concentrations of nanoparticles showed a greater signal 
intensity compared to lower nanoparticle concentrations. Detailed testing data can be seen in 
Appendix E: Dilution Testing of Nanoparticles. 
 
 
Figure 23: Nanoparticle dilution testing setup with two replicates for each concentration. Moving across the 
different columns of this well plate from left to right, the concentration of the nanoparticle solution increases. The 
initial concentration is 0.1 mg/mL, followed by a concentration of 0.5 mg/mL. All subsequent concentrations span 
between 0.5 mg/mL and 5 mg/mL in increments of 0.5 mg/mL. 
4.2.3.2 Nanoparticles in PDMS  
The next method of interest involved the use of polydimethylsiloxane, referred to as 
PDMS, which is a biocompatible polymer created through the combination of a two-part silicone 
based organic polymer. The specific type of PDMS used for testing was Sylgard 184, which has 
a fast curing rate of 45 minutes at a low temperature of 75°C, making it extremely easy to 
prototype with and rapidly produce. PDMS was utilized in various ways for alternative design 
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testing with both the PyroScience nanoparticles and foils. The first study that was performed was 
a PDMS peel method in which 3 µL drops of nanoparticle solution at concentrations between 2.5 
mg/mL and 5 mg/mL in 0.5 mg/mL increments, were dropped onto a glass slide. The droplet was 
then allowed to dry at room temperature. After drying, uncured PDMS was dropped on top of 
each dried film of nanoparticles as illustrated in Figure 24. The glass slides were then put into an 
oven at 70°C for 50 minutes to allow the PDMS to cure. A large amount of residual nanoparticle 
solution was left on the glass slides after peeling off the PDMS, resulting in low nanoparticle 
concentrations on the PDMS and signal intensities below the 50 mV threshold. Due to the 
insufficient signal intensities from this method, the nanoparticles were mixed with PDMS to 
prevent the nanoparticles from sticking to the glass slide, thus creating a higher nanoparticle 
concentration. However, this resulted in the nanoparticles being encased in the PDMS, which 
gave inaccurate oxygen readings. The complete data from these tests can be found in Appendix 
F: Nanoparticles in PDMS. 
 
 
Figure 24: Testing setup for PDMS stamp with nanoparticles testing. Nanoparticle solution was dropped on the slide 
and then PDMS was cured over the dried drop. 
4.2.3.3 PDMS Stamping 
 To determine means of effectively transferring the oxygen indicator solution to the 
device, PDMS stamping was explored as a possible option. In reference to this project, PDMS 
stamping involves exposing a raised pattern on pieces of PDMS to the indicator solution and 
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placing the exposed stamp onto a piece of COC. In theory, the indicator will transfer from the 
PDMS onto the COC, thereby distributing the solution across the surface in that pattern. 
 Two methods were explored as means of exposing the PDMS to the indicator solution. 
The first method involved placing a PDMS stamp in a bath of nanoparticle solution and allowing 
the stamp to sit in the solution for a set period of time as seen on the left in Figure 25. The 
second method involved placing the nanoparticle solution directly onto the top of the PDMS 
stamp for a set amount of time as seen on the right in Figure 25. The PDMS stamp was exposed 
to the nanoparticle solution for 5 minutes and then transferred to a piece of COC patterned side 
down. Despite being able to transfer a visible pattern, the PDMS stamp proved ineffective at 
transferring the required amounts of nanoparticles for accurate intensity readings as illustrated in 
Figure 26. 
 
 
Figure 25: PDMS stamp soaking in a bath of nanoparticle solution (left) and a PDMS stamp with nanoparticle 
solution placed on the top, patterned face (right). These two methods were used to coat the PDMS stamp with the 
nanoparticle solution prior to placement on the COC surface. 
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Figure 26: Nanoparticles patterned onto a piece of COC at 20X (left) and residual nanoparticles on the PDMS stamp 
at 10X (right). There is a much more obvious prevalence of the nanoparticles on the surface of the PDMS stamp as 
opposed to the surface of the COC. 
4.2.3.4 Dried Film 
 The team dropped the nanoparticle solution onto pieces of COC. This resulted in a 
clumpy and dense droplet of nanoparticles due to the hydrophobicity of the COC, as seen in 
Figure 27 below. This clumping caused a significant impedance of optical clarity. 
 
 
Figure 27: Dried droplet of nanoparticle solution onto the COC at 10X. This image shows the clumping that can 
occur in accordance with the static nature of the nanoparticles and hydrophobicity of the COC. 
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In an attempt to obtain a more even distribution of nanoparticles, the team explored salts 
and detergents as means of modifying the surface tension of the solution. This testing resulted in 
a more even distribution of the nanoparticles. However, these options were not pursued because 
the detergent would modify the cellular environment and the salt left apparent crystals that 
impeded optical clarity. Further results of this testing can be seen in Appendix G: Nanoparticle 
Dried Film. 
 To avoid this clumping without altering the chemistry of the indicator dye, the team 
altered the surface chemistry of the piece of COC by plasma treatment. Prior to plasma 
treatment, the contact angle of the nanoparticle solution on COC was measured to be 66° versus 
a contact angle close to zero after plasma treatment, these results are qualitatively shown in 
Figure 28. 
 
 
Figure 28: Nanoparticle solution on the surface of plasma-treated COC (left) and on untreated COC (right). As 
shown, there is a much more significant distribution of the nanoparticle solution on the surface of the oxygen plasma 
treated COC. 
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4.2.3.5 Narrowing the Nanoparticle Preparation Method 
 After experimenting with the four different preparation methods of the nanoparticles, the 
team determined that the best option to pursue was the dried film on a plasma treated COC 
surface. This method yielded a sufficient distribution of particles and adequate signal intensity. 
Mixing the nanoparticles in aqueous solution was determined to not be a feasible option due to 
the need for contaminating device media. Mixing the nanoparticles with PDMS also had a low 
signal intensity and any oxygen readings would be inaccurate due to complete encapsulation of 
the nanoparticles in PDMS. PDMS stamping was determined to be ineffective due to lack of 
sufficient transfer and a corresponding low signal intensity. 
4.3 Format Implementation Testing 
 Based on the dye having a height higher than the required specifications and the 
nanoparticle dried film not completely adhering to the COC, the team looked to using heat and 
pressure to flatten and adhere the formats to the COC. This led the group to use a Carver press to 
embed the particles into the surface of the COC by heating it to just below the glass transition 
temperature. Figure 29 below displays the setup used for the Carver press method. 
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Figure 29: Carver press setup. As shown, the Carver press involves the use of two heated platens designed to apply 
set amounts of temperature and pressure over a pre-specified time interval. The COC and sensor format is placed 
between layers of Kapton, aluminum, and rubber. The rubber primarily act as a compliance layer and fosters heat 
transfer to the COC. 
 
 The initial Carver press settings were 120°C at 250 psi for 15 minutes. This initial testing 
was performed on three samples of COC with dried nanoparticles. This testing had some 
surprising results as it appeared that the core of the nanoparticles were made of a polymer with a 
transition temperature at or below that of the COC which caused the particles to flatten and 
spread as the polymer melted. In accordance with this spreading, the team noted that the pressed 
samples showed significant improvements in optical clarity as illustrated in Figure 30.  
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Figure 30: Nanoparticles before Carver press processing (left) and nanoparticles after initial Carver press processing 
(right) at 10X. As shown, the particles are much more distributed across the surface of the COC due to the pressure 
and temperature of the Carver press. Additionally, following processing with the Carver press, the nanoparticle 
mixture allows for much less optical impedance, as shown by the lighter color of the nanoparticles, which indicate 
that more light is able to pass through. 
 
The team also processed a PyroScience dye droplet sample using the Carver press at 250 
psi of pressure at 120°C for 15 minutes. This test was performed to determine if the dye would 
act similarly to the nanoparticles by creating an optically clear layer as well as reducing the 
height of the drop. Images taken prior to and following this pressing can be seen in Figure 31. As 
shown, there was a much more uniform layer across the surface where the droplet was, though 
there was still significant amounts of opacity that affected the overall optical clarity of the 
indicator causing it to be rejected for future analysis. 
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Figure 31: Dried hydrophilic dye droplet on COC prior to Carver press processing at 10X (left) and the dried 
hydrophilic dye droplet on COC after using the Carver press at 10X (right). Similar results to that of the 
nanoparticles following processing with the Carver press were seen, being that the dye is much more evenly 
distributed than prior to the Carver press processing. 
4.4 Durability Testing 
Each of the samples of COC were put through durability testing after being processed in 
the Carver press to determine if the formats were sufficiently adhered to the COC. This testing 
included a light wash, a heavy wash, and two scratch tests. Before all testing, a marker was 
placed on the pressed area and an image was taken using the confocal microscope to ensure that 
the same area was being imaged each time. The light wash consisted of a continuous light spray 
of DI water for five seconds onto the dried drop of nanoparticles. During the heavy wash, the 
team vigorously rinsed the piece of COC for five seconds. After the wash test, a scratch test was 
performed using a plastic pipette tip, which was dragged across the surface of the pressed area. A 
second scratch test was performed using a metal point, which was also dragged across the 
surface of the pressed area. After each round of testing, an image was taken for comparison with 
the original to see if anything was removed from the surface. For almost all, this testing had no 
effect on the pressed sample. 
A tape test was also performed on some of the samples to see if the particles could be 
removed. A premium lab grade labeling tape was used and the group saw that some of the 
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nanoparticles had been lifted off with the tape, as seen below in Figure 32. The team concluded 
that this test removes a portion of the nanoparticles. However, this effect was not concerning, 
because the results were not representative of how the particles would be used in the final device. 
When in use, the nanoparticles would not experience normal tensile forces that are generated 
when removing the tape. 
 
   
Figure 32: Before (left) and after (right) tape testing at 10X. Significant amounts of the nanoparticles were removed 
following the tape testing. However, these tests are deemed to not be representative of the conditions under which 
the device will operate. 
 
Both the nanoparticles and dye saw more desirable characteristics after processing with 
the Carver press and based on initial durability tests, were sufficiently adhered to the COC. 
Based on these results, this method was chosen as the final mean of sensor format 
implementation for this project.  
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CHAPTER 5: DESIGN VERIFICATION 
After determining that the Carver press method was the best for implementing the oxygen 
indicator, a series of validation tests were designed and run on the foil, nanoparticle, and dye 
formats to determine the final design. These tests aligned with the constraints of the project and 
included an optical clarity test, a soak test, a thermal test, a sterilization test, and an oxygen 
duration test using the PyroScience Piccolo2. 
5.1 Optical Clarity Testing 
The team used histological slides of a section of human skin tissue to test optical clarity 
using the method illustrated in Figure 33. 
 
 
Figure 33: Test method for evaluating the optical clarity of each sensor format. The sample of COC with the sensor 
format patterned on it was placed on top of a glass coverslip, which was then placed on the microscope stage. The 
histological section adhered to a glass slide was placed directly on top of the sensor format sample.  
 
Figure 34 shows half-overlaid comparisons between each of the sensing formats on top of 
and underneath the histological slide. The foil material on top of the slide allowed for very little 
of the tissue sample to be seen, while on the bottom, none could be seen. The pressed dye 
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allowed the tissue sample to be seen when on top, but not on the bottom. On the other hand, the 
tissue sample could be seen through the pressed nanoparticles on top and on the bottom of the 
slide. Imaging through the bottom represented the worst-case scenario because the microscope 
would have to look through the sensor format to focus on the biological sample. 
 
 
 
 
 
 
Figure 34: Foil material on top of histological slide (top left), foil material under histological slide (top right), 
pressed dye on top of histological slide (middle left), pressed dye under histological slide (middle right), pressed 
nanoparticles on top of histological slide (bottom left), and pressed nanoparticles under histological slide (bottom 
right) all at 10X. 
57 
 
5.2 Verification of Durability Testing 
For the soak test, thermal test, and sterilization test, the team used the PyroScience 
Piccolo2 to test the integrity of the sensor by comparing intensity readings before and after the 
test. To do this, the sample was placed in a 12 well polystyrene cell culture plate and the Piccolo2 
was held flush to the bottom of the plate, as seen in Figure 35. The thickness of the polystyrene 
plate, meaning the distance between the fiber optic and the sensor format, was 1.8 mm. The 
Piccolo2 was allowed to stabilize and then the signal intensity was recorded for each point of 
interest.  
 
 
Figure 35: Piccolo2 test method for validating the integrity of the sensor format after soak, thermal, and sterilization 
testing. The Piccolo2 sensor was held flush to the bottom of a 12 well cell culture plate and the signal intensity was 
recorded.  
5.3 Soak Testing 
 One form of validation that the group tested the samples with was a soak test, designed 
based off recommendations from ASTM standard C1247-14. In preparation for this, a 3 mm foil 
circle was placed in a drop of PDMS on a cut piece of COC, a 3uL drop of 40 mg/mL 
nanoparticle solution was placed onto COC and pressed, and a 3uL drop of hydrophilic dye was 
placed onto COC and pressed. Signal intensity data and images were gathered for all samples. 
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Each of these samples were then placed in contact with 2 mL of standard cell culture media in a 
well of a 12 well cell culture plate, as seen in Figure 36 below. The media is comprised of 10% 
fetal bovine serum (FBS), 1% Penicillin Streptomycin, 1% GlutaMAX supplement, and 88% 
Dulbecco’s Modified Eagle Medium (DMEM). These samples and media were put in an 
incubator at 37°C. After 14 days, each sample was tested for signal intensity and imaged on the 
inverted microscope. 
 
 
Figure 36: Diagram of the sensor format sample in 2 mL of cell media in one well of a 12 well cell culture plate. 
 
 
The data displayed in Table 7 showed that the signal intensity for the hydrophilic dye 
sample increased after 14 days, the nanoparticles decreased to an inadequate signal intensity, and 
the foils decreased but stayed above 50mV. The decrease in signal intensity below the 50 mV 
threshold for the nanoparticles was due to a low concentration of the prepared nanoparticle 
solution. However, this could be easily remedied by using a higher concentration of 
nanoparticles meaning that all sensor formats have the ability to withstand 14 days in cell culture 
media. 
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Table 7: Signal intensity readings before and after the soak test. 
 
5.4 Thermal Testing 
 Another validation test that the group performed was a thermal test, which was designed 
in accordance with ASTM D7895/D7895M-14. This was done to ensure that the signal intensity 
of the samples would not be affected during Draper’s fabrication process of the organ-on-a-chip 
device. In preparation for this test, a foil circle was placed in a drop of PDMS on a cut piece of 
COC, a 3uL drop of 40mg/mL nanoparticle solution was placed onto COC and pressed, and a 
3uL drop of hydrophilic dye was placed onto COC and pressed. Signal intensity data was 
collected and images were taken on an inverted microscope for each sample prior to the thermal 
test. The samples were then placed in an oven at 120°C for one hour, as seen in Figure 37 below, 
and signal intensity data and images were collected after the test. 
 
 
Figure 37: Nanoparticle and dye resting on a glass slide in the oven during the thermal test. 
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Table 8 shows that all of the samples maintained a sufficient signal intensity after thermal 
testing. 
 
Table 8: Signal intensity readings before and after the thermal test. 
 
5.5 Sterilization Testing  
Being that the final microfluidic device is subjected to ethylene oxide (EtO) sterilization, 
the sensor format must be able to provide accurate readings following this processing, as seen in 
Figure 38. All samples were subjected to EtO sterilization for a period of 12 hours. The samples 
were then left on the bench top for a period of 24 hours to degas. This testing was designed based 
off recommendations from ISO 11135:2014. 
 
 
Figure 38: Diagram of ethylene oxide sterilization. 
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 As shown in Table 9, there was not significant variability in the signal intensity readings 
prior to and following EtO sterilization. 
 
Table 9: Signal intensity readings before and after the ethylene oxide sterilization. 
 
5.6 Duration Testing 
 To assess the stability of each format’s oxygen percentage readings, duration testing was 
conducted. This test consisted of performing a two-point calibration for each format in an 
incubator at 37°C using a solution of 21% oxygen DI water for a 21% point and a solution of 30 
g/L sodium sulfite for a 0% point. Post calibration, each format was submerged in a 21% oxygen 
DI water solution and read using the Piccolo2 inside an incubator for the span of an hour. The 
PyroScience software took samples every second at a fixed intensity. Both the oxygen 
percentage and signal intensity were monitored and recorded in real time. The signal intensity for 
all three samples was above the 50 mV threshold and the Piccolo2 was held at a distance 1mm 
away from the sensor format. 
The results of the Piccolo2 duration testing for each sensor format are illustrated in Figure 
39. Both the foil and the nanoparticle samples appeared to reach stable oxygen percentage levels 
by the end of data collection. On the other hand, the dye sample continued to display a 
downward trend even at the tail end of the 4,000 seconds of data collection.  
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Figure 39: Graph illustrating the results of oxygen percentage data collection over a 4,000 second time interval using 
the Piccolo2. Each sample was placed in a 21% oxygen DI water solution and the fiber optic was placed a distance 
of 1 mm away from the sensor format.  
 
For further analysis, an eight-minute segment of data at the end of each test was isolated 
for each format and statistically analyzed which can be seen in Figures 40, 41, and 42. Each 
segment was fit with a linear trend line to evaluate how stable the signal was, an average was 
calculated to assess how close the recorded oxygen percentage matched the expected 21% value, 
and a range was calculated as a mean of assessing the stability of the signal. All calculated 
averages and ranges are located in Table 10. 
 
Table 10: A table outlining the averages and ranges of eight-minute segments of oxygen percentage data for each 
sensing format. 
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Although the foil was stable which is seen by the small slope of -5 x 10-5 %O2/sec, the 
foil had an average of 18.5% which was below the expected 21% value. This data can been seen 
in Figure 40 below. 
 
 
Figure 40: A graph showing an eight-minute segment of the foil oxygen percentage data taken from the end of the 
graph seen in Figure 39. 
 
Based on the negative slope shown on the graph in Figure 41, the team concluded that the 
dye format never achieved a completely stable reading after being given an hour to acclimate to 
standard oxygen levels. This indicates that the dye will not be able to obtain accurate oxygen 
readings over an extended period of time. 
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Figure 41: A graph showing an eight-minute segment of the dye oxygen percentage data taken from the end of the 
graph seen in Figure 39. 
 
As seen in Figure 42, the nanoparticles proved to be the most stable and accurate sensing 
format with an average oxygen percentage of 20.1%, a range of 0.082 %O2, and a slope of -6 x 
10-5 %O2/sec. 
 
 
Figure 42: A graph showing an eight-minute segment of the nanoparticle oxygen percentage data taken from the end 
of the graph seen in Figure 39. 
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5.7 Final Design Selection 
 Based on the verification tests discussed above, a Pugh analysis, shown in Table 12, was 
performed using the pairwise comparison chart of the design constraints, found in below in Table 
11.  
 
Table 11: An image of the pairwise comparison chart used to determine the desired characteristic of the final device. 
The characteristic corresponding to the highest number in the “Total” column is considered to be the most highly 
prioritized constraint; subsequent constraints were ranked based on the decreasing order of importance associated 
with decrease in number. 
 
 
The Pugh analysis used the weights determined from the pairwise comparison chart to 
rate each alternative design. The first two columns of the Pugh analysis table contain the design 
constraints and their respective weight, referred to as ‘Importance’. The third column defines the 
baseline used in Draper’s current system for comparing the alternative designs. The baseline 
design is ranked at zero for each characteristic. In subsequent columns, a value of ‘1’ indicates 
that the alternative design outperforms the baseline. Additionally, a ‘0’ signifies that the design 
performs as well as the baseline, with a ‘-1’ indicating the design performs worse than the 
baseline. These values multiplied by the importance of each constraint sum to determine the final 
score of each design. These final scores determine the ranking of the design. 
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Table 12: Table of the Pugh analysis to determine the best design to move forward with during final prototyping and 
experimentation processes. As shown, the nanoparticles and hydrophilic form of the dye each received equal 
rankings of preference. 
 
 
The nanoparticles and hydrophilic dye ended with the same total score of 2. However, the 
nanoparticles were noted to exceed the baseline foil in morphology/imaging while the dye met 
the baseline in this category. Since the weight of this constraint was zero it did not add or 
subtract from the total score of each design, but acts as a tiebreaker. The nanoparticles had a ‘1’ 
in this category and the dye had a ‘0’, therefore the nanoparticles were selected as the final 
design to be subjected to further validation testing.  
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CHAPTER 6: FINAL DESIGN AND VALIDATION 
The team’s final design consisted of a concentrated drop of nanoparticles that had been 
processed using a Carver press onto COC. The design was put through validation tests to 
determine optimal fabrication parameters. Various conditions were iterated upon to determine 
how altering Carver press pressure or method time would affect the topography and adherence of 
the sensor layer to the COC. An automated liquid handler was also used to prove that the final 
design could be easily incorporated into Draper’s final device. Additionally, the verification 
testing used throughout this project was rationalized against common industry standards. The 
ethical, health and safety, and manufacturability ramifications of this final product were also 
analyzed. 
6.1 Carver Press Method Condition Testing  
 The initial conditions used in the preliminary Carver press testing, consisted of applying a 
pressure of 450 psi, at a platen temperature of 120oC for a duration of 15 minutes. The team 
desired to determine the effects of varying both pressure and total time while keeping the 120oC 
platen temperature constant. From this, three additional conditions were identified as illustrated 
in Figure 43 where point one indicates the initial Carver press testing conditions. The new 
conditions consisted of keeping the same 15 minute time and increasing the applied pressure to 
900 psi (point 3), halving the time and keeping the same pressure of 450 psi (point 2), and finally 
halving the time and increasing the applied pressure to 900 psi (point 4). Specimen for this 
testing were prepared by depositing a 3 μL drop of solution onto a piece of COC that had been 
oxygen plasma treated for one minute. 
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Figure 43: Graph illustrating the four sets of points used to select the optimal Carver press method conditions. The 
different conditions are shown as points labeled as 1, 2, 3 and 4. This figure shows the variability of time and 
pressure during the testing with the Carver press.  
6.1.1 Condition Testing: Point 1 Results 
 Figure 44 illustrates the confocal images of the point one condition testing in which 450 
psi of force was applied to the sample over a 15 minute timeframe. After applying the heat and 
pressure cycle, it was noted that the polymer layer appeared to melt under the temperature 
conditions effectively gluing the dye down to the COC surface. This melting of the polymer 
layer resulted in an apparent clear film of the dye solution, which had a significantly more 
uniform distribution after pressing compared to before the pressing procedure. As previously 
mentioned, a layer of Kapton tape was used in the pressing stack-up. The Kapton tape can 
operate at extremely high temperatures and acts as a non-adhesive surface on the aluminum 
blocks used during Carver pressing. During the testing for the sample under condition one, some 
of the polymer dye residue peeled off onto the Kapton tape. This phenomenon is visible in 
Figure 44, through the jagged pattern on the boundary between the sensor format and COC. 
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Figure 44: Inverted confocal microscope image of sample N1 at 10X magnification.  
6.1.2 Condition Testing: Point 2 Results  
 Figure 45 illustrates a confocal image under 10X magnification for testing under 
condition two with 450 psi of applied pressure for 7.5 minutes. Compared to the first condition, 
the sample did not appear to be pressed for a long enough duration to achieve the clear spread 
out melted polymer and dye layer, as shown in Figure 45. As shown in Figure 45, this sample 
showed some melting of the polymer, which was visible under a higher magnification, but it was 
clear that more time was important to the uniformity and clarity of the sensor polymer layer. 
 
 
Figure 45: Inverted confocal microscope image of sample N2 at 10X magnification (left) and sample N2 at 40X 
magnification (right).  
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6.1.3 Condition Testing: Point 3 Results 
 Figure 46 illustrates the post press image of the sample for the third testing condition in 
which 900 psi of pressure was applied to the specimen for 15 minutes. The sample under this 
iteration yielded a uniform sensor polymer layer that was much more transparent than post press 
images of the same samples. 
 
 
Figure 46: Inverted confocal microscope image of sample N3 at 10X magnification. 
6.1.4 Condition Testing: Point 4 Results  
 Figure 47 illustrates the results of the Carver press condition four testing, in which 450 
psi was applied for 7.5 minutes. Similar to the results of the testing from condition one and three, 
the sample had a clear and seemingly uniform distribution of the sensor polymer layer over the 
COC surface. 
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Figure 47: Inverted confocal microscope image of sample N4 at 10X magnification.  
6.2 Surface Topography Analysis of Conditions 
 After pressing, the team utilized an Olympus LEXT OLS4100 3D laser measuring 
microscope to analyze the surface topography of the samples. This was important to determine if 
the polymer dye solution was being pressed into the COC after being heated to its glass transition 
temperature, which is between 80oC and 180oC depending on the specific grade of COC used, or 
if the material was just adhered to the COC surface as a thin film. 
6.2.1 Laser Confocal Conditions One Through Four Results 
 Each sample was imaged using the LEXT microscope with the 50X lens after the Carver 
press method. Images were taken in the region where the sensor polymer layer tapered off and 
specialized software was utilized to measure the height of the sensor polymer layer on each 
sample at various points. Figure 48 illustrates an example of the analysis for a sample under the 
first set of Carver press conditions. The left hand portion of the image illustrates the region that 
was analyzed by the microscope, which is differentiated using a green box. The right hand 
portion of the image illustrates a topographic map of the sample. Similar images for the rest of 
the samples can be found in Appendix H: Laser Confocal Analysis. 
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Figure 48: Laser confocal analysis of sample N3 using 50X lens. Area of sample being analyzed by laser confocal 
(left) and topographic map of area of interest (right) 
 
Each sample was analyzed as illustrated above in Figure 48 and the height of the sensor 
polymer layer off the COC surface was measured for the region of interest. The height 
measurements for each sample are illustrated in Table 13. The height of the sensor layer at a 
point towards the edge of the drop was found to vary from 0.715 μm to 1.62 μm. Definitive 
conclusions on the height of the sensor layer cannot be drawn from these studies since this 
method measures the height at one small point from the entire sample. The major conclusion 
gained from this analysis was that the sensor polymer layer was not fully embedded into the 
COC surface, but exists as a thin micron-sized layer over the surface of the material. 
 
Table 13: Heights determined and location measurement for each of the samples analyzed using laser confocal 
imaging. The left column of the table indicates which sample is being studied, the middle column shows the 
measurement of the sample height, and the right column shows the location at which the height was measured. 
Sample ID Measurement (μm) Location 
N1 0.869 Edge 
N3 1.62 Edge 
N4 0.715 Edge 
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A single height measurement was not able to be made for sample N2 due to the lack of a 
uniform distribution of the sensor polymer layer. The region of interest analyzed and the 
topographic map for this sample are illustrated in Figure 49. The peaks of the nanoparticle 
clusters were seen to be up to 10 μm in thickness. The peak heights in this sample were 
significantly higher than those seen in the samples pressed at a higher pressure or for a longer 
duration of time. This supports the previous conclusion that the sample under the 450 psi applied 
force for 7.5 minutes did not sufficiently press the sensor dye compared to previous testing. This 
was further confirmed by the fact that a sample of a dried drop of nanoparticle solution imaged 
without undergoing the Carver press method measured peak heights of around 20 μm. Thus, it 
can be concluded that the N2 sample was pressed to some extent since the peak heights were 
between the typical pressed samples and the non-pressed samples. However, this set of pressing 
conditions was deemed ineffective due to a lack of clarity and uniformity in the sensor layer as 
seen in Figure 49. 
 
 
Figure 49: Laser confocal analysis of sample N2 using 50X lens. Area of sample being analyzed by laser confocal 
(left) and topographic map of area of interest (right). This topographical map shows the height difference across the 
surface of the sample following processing using the Carver press. 
74 
 
6.3 Automation Validation 
 An automated liquid handler, a Beckman Coulter Biomek 2000, was used to deposit an 
array of 3 µL nanoparticle drops on a plasma treated COC surface as illustrated in Figure 50. The 
purpose of this round of testing was to ensure the feasibility of easily incorporating the 
nanoparticle format into Draper’s device. Due to limitations of the machine used, the smallest 
drop size able to be attained was roughly 3 mm in diameter, which did not fit within the 300-800 
µm diameter size specification necessary for incorporation into Draper’s device. To remedy this, 
the team collaborated with the maker of the chemical indicator to use a machine with higher 
resolution to drop the hydrophilic dye solution in an array of 96 dots with diameters ranging 
from 200 to 600 µm as illustrated in the right hand image of Figure 50. The higher resolution 
device showed success in generating an appropriately scaled array of the indicator dye; the team 
believes this success is applicable to the nanoparticle solution if the same equipment is used.  
 
 
Figure 50: Automation validation of nanoparticle solution. The left hand image illustrates an array of 16 
nanoparticle dots dropped on plasma treated COC. This process needs to be scaled down to be applicable in 
Draper’s device. This was achieved through collaboration with the creator of the chemical indicator and the use of 
the Vermes’s Micro Dispensing Valve as illustrated in the right hand image.  
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The array of dots produced using the Beckman Coulter Biomek 2000 were tested for 
signal intensity before and after being put through the standard Carver process procedure to 
ensure functionality of the sensor format. Prior to the Carver press process, the drop signal 
intensity averaged 176.56 ± 23.09 mV with a maximum drop signal intensity of 210 mV and a 
minimum of 133 mV. After the Carver press process, the drop signal intensity averaged 94.12 ± 
32.39 mV with a maximum drop signal intensity of 129 mV and a minimum of 4 mV. The 4 mV 
signal intensity was because one of the drops had peeled off the COC when removing the sample 
from the testing stack-up. This indicates that there is a decrease in signal intensity associated 
with the pressing process. However, this decrease was not high enough to result in intensities 
below the 50 mV threshold, meaning the sensor format can still be accurately used with the 
Piccolo2 sensor. The Carver press procedure also resulted in a more uniform distribution of 
nanoparticles as well as increased optical clarity as expected and illustrated in Figure 51. 
 
 
Figure 51: Automation drops pre (left) and post (right) Carver press processing. The uniformity and increase in 
optical clarity of the sensor layer were seen as expected after processing.  
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6.4 Standards 
All testing was compared against established standards as means of validating that good 
practice is followed throughout the course of the project. 
6.4.1 Scratch Test 
The parameters for the scratch test were identified based on the ASTM standard D7027, 
which provides a standard test method for evaluation of the scratch resistance of polymeric 
coatings and plastics. The purpose of this standard is to provide a repeatable way to evaluate 
surface damage of coatings after being exposed to a controlled set of conditions. Test Mode B of 
this standard was most closely adhered where a constant normal force of 30N at a scratch rate of 
0.1 m/s is applied to a 0.1 m length of the sample [43]. These standard parameters could not be 
replicated exactly due to lack of access to an instrumented scratch machine; however, the team 
was consistent with who performed each scratch test in hopes of maintaining a constant load and 
scratch rate from sample to sample. A downside of performing scratch tests in this manner is the 
presence of user-influenced effects, like scratching the surface of the sensor format with a 
different force during each test. 
6.4.2 Soak Test 
 When designing the soak test, the team considered the ASTM standard C1247-14 which 
details a test method for evaluating the durability of sealants that must function in environments 
subjected to continuous immersion in a liquid. This standard is concerned with how well the 
sealant is able to maintain adhesion to a substrate after liquid immersion for a set amount of time. 
The sensor formats being tested are not directly applicable to this standard since they are not 
sealants, but the method described is still relevant since the sensor format sample must be 
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durable in continuous immersion in cell culture media. The test method for this standard includes 
specimen preparation and immersion of the sample in liquid at 50°C for six weeks. After the 
soak test is completed, the sample is subjected to compression and extension loads with testing 
parameters specific to the intended use of the specimen [44]. The team followed the idea of this 
test method, but changed the soak and post soak testing conditions to match how the sensor 
format will be used in Draper’s final device. For instance, the temperature of the media was set 
to be 37°C and the soak duration used was 14 days per client specifications. Additionally, the 
format was determined to maintain integrity after the soak test with signal intensity validation 
with the current optical platform. 
6.4.3 Thermal Test 
The team based the experimental procedure for the thermal test off ASTM standard 
D7895/D7895M-14 which details a test method for testing the thermal endurance of coating 
powders used for powder coating insulation systems. This standard details a procedure to 
determine how resistant coating powders are to exposure to elevated temperatures. Although this 
standard is specifically designed for insulating powders used on steel, it was determined that the 
general method used in this standard was applicable to the testing of each sensor format on a 
COC substrate. The testing parameters of this standard include aging each sample at three 
different temperatures above the samples operation temperature. After exposure to elevated 
temperatures, the materials are tested using a dielectric proof voltage test to quantify when any 
degradations in thermal endurance occur during testing at elevated temperatures [45]. Since only 
the ability to withstand thermal cycling at 120°C for one hour was necessary to prove the 
functionality of the sensor format on COC from a thermal endurance standpoint, these 
parameters were adopted for testing as opposed to three different temperatures. Additionally, 
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performance was evaluated by comparing the signal intensity output of the Piccolo2 sensor 
before and after thermal testing. This evaluation metric was chosen based on how the sensor 
format needs to perform in Draper’s final device. 
6.4.4 Ethylene Oxide Test 
All processing in ethylene oxide sterilization was done per ISO 11135:2014 standards. 
Specifically, this standard focuses on the regulations regarding the sterilization of health-care 
products through ethylene oxide. Emphasis within this standard is placed upon the requirements 
for the development, validation and routine control of a sterilization process for medical devices. 
6.5 Ethical Concerns 
 The organ-on-a-chip system under development at Draper seeks to produce a positive 
impact on the healthcare and drug development industries by bringing helpful drugs to market 
faster. Additionally, this organ-on-a-chip device serves as a versatile testing platform for the 
field of research and development without damaging or degrading the lives of the public or 
research community. In fact, this organ-on-a-chip device will ideally reduce some of the most 
prominent ethical concerns related to the healthcare industry, specifically animal testing.  
Currently, new procedures and medicines are required to undergo animal studies, which 
utilize animals such as mice, rabbits, and pigs for validation of the safety and efficacy of the new 
treatment prior to entering the market. While the FDA has made great strides to prevent suffering 
or unnecessary damage to the animal test subjects, the act of using animals for these studies still 
produces an ethical dilemma. The dilemma being, is it right to subject animals to these 
treatments, which regardless of the success of the test, requires the testing subject to be put 
down. The development of Draper’s organ-on-a-chip technology and associated oxygen sensing 
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capabilities will help to disrupt the industries dependency on animal studies by providing them 
with a more accurate and cost effective alternative. Although this technology has yet to be fully 
validated, it has the potential to alleviate the medical research industry of the ethical dilemma of 
performing extraneous iterations of animal studies. 
6.6 Health and Safety Issues 
  The broader focus of Project SOAR was to increase the health of individuals that rely on 
the readings of these organ-on-a-chip devices. By extension, this project provides the pre-
existing organ-on-a-chip technology with a means for increasing the accuracy of its results. The 
addition of oxygen sensing acts as an indicator of cell health which results in an understanding of 
the effects an experimental drug is having on cells. With this knowledge, researchers have a 
better likelihood of producing results that are more predictable and translatable to human trials. 
Effectively, this helps researchers produce fewer results that are categorized as false positive, in 
which the tests say the drug is safe but in actuality it is not, or false negative, in which the tests 
say the drug is not safe but in actuality, it is. Either of these scenarios can be potential health 
risks to the public since patients may be exposed to dangerous drugs or miss out on potentially 
lifesaving medicines. The addition of the team’s oxygen sensing capabilities to the current 
platform will be able to screen drugs and determine the most promising candidates for rapid 
advancement through the FDA process. 
  The manufacturing process poses minor risks to individual’s health and safety due to the 
required heat and pressure associated with the process of producing the oxygen sensing 
components. The heat required for production of the oxygen sensitive component reaches 120oC, 
which can cause serious burns if handled without proper personal protective equipment, PPE. 
Additionally, the nanoparticles for the oxygen sensing component should not be ingested or 
80 
 
inhaled. The nanoparticles are extremely fine and staticy; therefore they should be handled 
carefully with PPE, such as gloves, glasses, and a face mask if necessary. 
6.7 Manufacturability and Sustainability 
One goal of the final design was for it to have the ability to be easily incorporated into 
large-scale manufacturing processes. Draper is looking for the ability to scale the team’s method 
for producing an oxygen sensing format to their 96 well device for further research. This means 
that the team’s process of producing a working oxygen format does not need to be produced at a 
high volume; instead, it must be able to be produced in a handful of devices per week as the 
format is still undergoing research. 
The team has defined an implementation process for manufacturing of devices 
incorporating the new sensor format which can be automated for anywhere from one sensor to 96 
sensors. Specifically, the team tested the nanoparticle dropping method in coordination with the 
thermal bonding process used for creating the full device on the scale of multiple drops. The 
results of these tests have proved to be successful which acts as a means of validating the 
feasibility of scaling to the 96 well format. Additionally, the bonding process of the nanoparticles 
to the base COC follows the same conditions as the final bonding conditions for fabricating the 
96 well device. Therefore, it is much easier for Draper to incorporate this additional step into 
their predefined fabrication methodology. To further validate this option as the best, the team 
explored other means of implementation such as PDMS stamping. This option consisted of 
creating PDMS stamps with a specific pattern of circles to match the desired diameter of the 
sensor format, which was exposed to a surface treatment making the stamp more hydrophilic. 
Next, the stamps were exposed to a solution of the sensing format, which was subsequently 
stamped onto the COC to transfer the solution in the desired pattern. Due to the size and 
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clumping properties of the sensing formats this option did not transfer enough material over to 
the COC which means further surface treatments would be required to increase adhesion or more 
solution of the sensing format would have to be used. This process also wasted a sizable volume 
of the sensing format solution making this process inefficient and costly. 
Although the bonding process can be incorporated into Draper’s current fabrication 
techniques, the creation of nanoparticle solutions and the method of depositing them onto the 
surface requires additional steps. The team determined that a 3 µL drop of 40 mg/mL 
nanoparticle solution provides a sufficient amount of nanoparticles for the accurate acquisition of 
oxygen data. The downside to this process is the need for nanoparticle solutions which not only 
require time to create but also have a high price for purchasing in bulk, $292.00 for 10 mg of raw 
nanoparticles, therefore making the material a restriction to scaling up to a 96 well format. The 
nanoparticle sensor format requires an automated mechanism for dispensing the solution over a 
surface at specific intervals to align with the center of each well. Draper’s current method is 
extremely manual labor intensive by placing each sensor format by hand, which allows on-the-
spot modifications to be made. However, this process takes time and personnel to complete, 
which also exposes the process to human error. One option to improve this process is an 
automated microplate dispenser, such as BioTek’s MultiFlo FX, which is able to dispense drops 
as small as 1 µL on a surface in a consistent manner with ± 5% accuracy in the form a 96 well 
format. Additionally, the Thermo Scientific Multidrop Combi nL Reagent Dispenser would be 
able to dispense drops as small as 50 nL. If a smaller volume is required for fabrication, the 
Vermes’s Micro Dispensing Valve - MDV 3200A is capable of dispensing drops at a volume as 
low as 1 nL. Once again, this addition requires more time and money to execute which reduces 
the feasibility of scaling up this process to mass production. 
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6.8 Economic Impact 
 A long-term impact of organ-on-a-chip devices, like the one worked with in Project 
SOAR, is to reduce costs associated with the FDA drug approval process. In recent years, the 
number of drugs approved through this process have declined which is quantified by an 88% 
drug development failure rate [46]. In parallel to this trend, research and development costs have 
climbed dramatically [47]. Both of these trends result in significant price increases for patients 
that are dependent on drugs developed through this process. To reduce these drug costs for 
consumers, organ-on-a-chip technology is meant to act as an intervention in the early stages of 
the process. The earliest stage of the drug approval process costs roughly $9.6 billion USD, 
which is the highest cost out of the four phases of the process besides clinical trials. An upwards 
of 10,000 compounds need to be vetted in this phase and organ-on-a-chip technology makes it 
much easier to test many compounds in bulk [48]. This technology will reduce development 
costs significantly in comparison to the animal models that are currently used. 
6.9 Environmental, Societal, and Political Effects 
 Microfluidic testing, as a whole, works at an extremely small-scale in an attempt to rid 
excess waste of materials. By limiting the amount of materials in use in the final device, while 
ensuring accuracy of all readings and data gathered during testing, researchers are able to limit 
the volume of chemical and biological waste generated. This lessens the environmental impact 
that often is of concern with regards to drug testing. Additionally, we considered waste caused 
by sterilization methods such as exposure to ethylene oxide, which results in the release of this 
highly toxic chemical into the air or sources of water [49]. 
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 The societal and political concerns associated with the final device are centralized around 
two main scopes: the mitigation of animal testing and the testing of potential medications. The 
goal of the final device is aimed at limiting the number of preliminary drugs that are tested on 
animals during the varying phases of preclinical and clinical testing. By better predicting drug 
success rates using organ-on-a-chip devices, researchers are able to limit the number of drugs 
progressing towards animal testing. On the same note, through the use of organ-on-a-chip 
devices, researchers are able to better streamline the drug testing process and improve the rate at 
which safe and useful drugs are able to reach market. This allows patients across the globe better 
accessibility to potentially life-saving medications.  
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CHAPTER 7: DISCUSSION 
7.1 Project Goals 
At the beginning of the project, the team defined goals to guide the direction of the 
testing and analysis of the sensor format. The major goals were defined as creating a means of 
sensing oxygen in Draper’s organ-on-a-chip device and creating a method of implementation for 
said format into the current system. The sensor format must be biocompatible, optically clear for 
imaging cells, accurate, adaptable for future iterations, compatible with automation efforts, and 
able to function in a cellular environment for the duration of up to 14 days continuously. Based 
off iterative testing exploring various options and techniques, the team was able to produce a 
result that fits Draper’s desired outcomes. Additionally, the goals defined above remained 
constant as the project progressed allowing the team to keep focused while sifting through the 
dynamic amount of possible solutions presented through research and testing. 
7.2 Discussion of Results 
 The results from testing primarily included, oxygen percentage and signal intensity 
readings from the Piccolo2, optical confocal microscope images, and laser confocal images and 
measurements. Each of these results helped the team determine the next steps in testing and 
eventually, which of the solutions proved to be the best. 
7.2.1 Piccolo2 Testing 
 Testing the various formats with the Piccolo2 provided quantitative data in the form of 
live oxygen measurements and signal intensity. The live feed of the oxygen measurements 
allowed for an understanding of the consistency and accuracy of the oxygen sensing format 
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being tested. The signal intensity was important in the process of selecting an effective 
concentration of nanoparticles required to produce a sensing format with accurate results. As 
defined in the methodology, a signal intensity of greater than 50 mV is recommended for reliable 
data acquisition. With this in mind, the team was able to iterate through various concentrations 
while having a means of validating their progress. The difficulty of this iterative process was 
finding a balance between the concentration and the strength of the signal. The ideal was a low 
concentration, to obtain the maximum level of optical clarity, with a high signal intensity, to 
obtain the maximum reading accuracy. Compared to Draper’s previous format, the foil material, 
the team was able to produce a more versatile format, nanoparticles, which can be fine-tuned to 
the desired signal strength. 
7.2.2 Optical Clarity  
 Another means for validating the team’s progress was the use an optical confocal 
microscope, which was a quick way to observe the effects of surface modifications, dilutions, 
and optical clarity. A majority of the results from this method were qualitative, allowing the team 
to visualize the power of surface modifications such as plasma treatment. Additionally, this also 
impacted the team’s decisions for dilutions since it allowed for a close up analysis of the packing 
of the nanoparticles which directly relates to the optical clarity of the sensor format. This 
visualization of the optical clarity was the defining factor in deciding which preliminary design 
was the best method to satisfy the design objectives and project goals. For example, qualitative 
optical clarity tests allowed the team to make the conclusion that the nanoparticles would be a 
better format to proceed with compared to the dye, which was too dense for optical clarity even 
after multiple dilutions and Carver press treatment. 
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 Similar to the optical confocal microscope, the laser confocal images provided the team 
with qualitative data of the topology of the various sensor formats. However, the laser confocal 
can attain higher resolution images at higher magnifications allowing for quantitative analysis of 
the topology on a micron scale. This analysis technique was critical for the team’s development 
of a method for utilizing the Carver press, since it showed how the nanoparticles were pressed 
onto the surface of the COC. The resulting product of the iterative process of tuning the Carver 
press’s pressure and processing time was a sensor spot of a much thinner thickness compared to 
Draper’s previous format. With a smaller thickness, the sensing obstruction of flow in Draper’s 
microfluidic channels caused by the sensing material decreases; in contrast, a larger thickness, 
such as the foil material, could cause turbulence in the channel. 
7.2.3 Soak Test 
 The data collected from the 14 day soak test provided insight into each format’s ability to 
function in a cell culture environment required for the final device. The dye and foil both seemed 
to withstand the environment of the media, while the nanoparticles ended the testing with an 
insufficient signal intensity. However, the dip below the 50 mV threshold for the nanoparticles 
was not determined to be noteworthy because the signal intensity prior to the soak test was 
already close to the 50 mV threshold. The foils also showed a similar magnitude of signal 
intensity degradation compared to the nanoparticles after the 14 day soak test; however, since the 
foil started with a higher signal intensity, this degradation did not push the value below the 50 
mV threshold. With this in mind, the concentration of nanoparticle solution used could be 
optimized to ensure that the small degradation in signal intensity after 14 days in media would 
not result in an insufficient intensity reading. 
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7.2.4 Thermal Test 
 The thermal test was meant to ensure that the chosen sensor format would be able to 
withstand Draper’s device fabrication parameters without degrading. All sensor formats were 
determined to not be sufficiently affected after one hour thermal cycle. The variations in signal 
intensity from the before to after testing were -5 mV, -8 mV, and 5 mV for the dye, foil, and 
nanoparticle samples respectively. None of the signal intensities dipped below the 50 mV 
threshold and the 5 mV and 8 mV degradation were not considered to be direct results of the 
exposure to the elevated temperature. The slight variation in signal intensity before and after 
testing was attributed to holding the fiber optic cable in slightly different positions below the 
drop between the readings. Since the concentration of the sensor format, for the dye and 
nanoparticles, is not completely uniform throughout the drop, it is logical that slight positioning 
variations of the fiber optic could result in signal discrepancies. Overall, all sensor formats 
exhibited sufficient thermal endurance to maintain integrity as a result of the thermal parameters 
of the current fabrication process.  
7.2.5 Ethylene Oxide Test 
 To ensure that the sensor format was able to withstand all sterilization parameters that are 
utilized with the current organ-on-a-chip device. Based on the current standards for sterilization 
used at Draper, the sensor formats were subjected to ethylene oxide sterilization treatments. The 
different sensor formats did not show significant variability prior to and following sterilization 
with ethylene oxide. The dye showed a decrease of 12 mV in signal intensity, while the 
nanoparticles and foils showed decreases of 15 mV and 11 mV, respectively. Experience has 
shown that such variability can be correlated with slight movements in the fiber optic during the 
testing procedure. 
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7.2.6 Duration Test 
 The purpose of the duration testing with the Piccolo2 was to provide an accurate depiction 
of the consistency of each format’s oxygen percentage readings over the span of an hour. Results 
from this test seen in Figure 39 showed an initial curve, which can be attributed to the change in 
temperature as a result of opening the incubator when setting up the test. As the temperature in 
the incubator reheated to 37°C the oxygen percentage of each format increased until a stable 
temperature was met. At this point, both the foil and nanoparticles leveled out at 18.6% and 
20.4% respectively while the dye seemed to decrease in percentage. This decrease could have 
been a result of residual 0% sodium sulfite calibration solution in the testing well or the tested 
dye had a fabrication defect. Overall, the nanoparticles was the closest to meeting the expected 
21% value over the span of an hour, however it did show a slight decrease over time. The foil, 
despite its consistency, leveled out below the expected 21%, which could have been due to 
human error during calibration. 
7.3 Limitations and Issues 
 Despite the success of meeting the project’s goals, the project was not without issues that 
complicated the team’s results. A major point noticed repeatedly in preliminary testing was 
clumping of the nanoparticles. Based on this, finding a way to evenly distribute the nanoparticles 
on the surface was essential. The nanoparticles were very staticy and seemed to be attracted to 
each other, causing them to clump up when drying due to the surface tension between the 
particles and the COC. This problem was addressed via the use of the Carver press to even out 
the clumpiness, however this did not remedy the entire issue. Some regions of the pressed dots 
showed a gradient of nanoparticle concentration across the surface or even a void in the sensor 
layer as illustrated in Figure 52. 
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Figure 52: Specimen illustrating voids commonly seen in pressed samples as a result of nanoparticle clumping 
during drying of the solution. To improve the current fabrication technique, the process should be reevaluated and 
replicated with the goal of lessening and removing these voids. 
 
Other attempts of resolving this issue included dispersing the nanoparticles in various 
detergents and organic solvents, but these attempts proved to be insufficient in breaking the 
clumps. Regardless of this issue, the pressed nanoparticles were still able to produce accurate 
Piccolo2 results and dots with sufficient optical clarity. 
 A constant limitation to the collected data was the Piccolo2’s inability to account for an 
environment with a dynamic range of temperatures. The importance of controlling the 
temperature was determined through initial studies and is illustrated in Figure 53. At two points 
during testing, as illustrated by the arrows, a member of the team breathed on the sample to 
increase the temperature. This resulted in a nearly instantaneous decrease of about 3% in the 
oxygen percentage reading, which leveled back off when the temperature was allowed to 
stabilize. Thus, it was very important to be cognizant of the temperature fluctuations in the 
environment during testing with this optical platform as even the air conditioning in a room 
caused excessive noise in the form of oxygen percentage fluctuations. 
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Figure 53: Oxygen percentage versus time for testing of dried nanoparticle films on a glass slide. Arrows indicate 
temperature sensitivity of the sensor due to breathing on the specimen to create a temperature increase during 
testing. 
  
To reduce the Piccolo2’s exposure to the environment a custom containment chamber was 
constructed out of a cardboard box. This creation significantly reduced the noise from the 
environment, however even the slight temperature variations in the box still manifested as drift 
in the oxygen percentage over time in some tests. A long-term fix for this issue would be the use 
of the FireStingO2, or another optical platform, which has the ability to actively normalize the 
temperature variations in real time. Despite this limitation, the team was able to acquire relevant 
data for validation of the tested formats. 
 Another issue that was encountered when utilizing the Piccolo2 was the duration of time 
required for the team to perform the two point calibration before each test. Two-point calibration 
was performed using a 21% oxygen DI water solution and a 0% oxygen sodium sulfite solution. 
While the sensor readings stabilized quickly when using the 0% oxygen solution, the 21% 
oxygen DI water often required extensive amounts of time – from a half an hour to three hours – 
to reach a stable oxygen reading. The team hypothesized the solution took a long time to 
stabilize because the equilibrium oxygen percentage of the solution was disrupted during transfer 
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into the testing environment. One limitation encountered during Piccolo2 testing was the inability 
to confirm that the 21% oxygen DI water truly was 21%.  
 The implementation of the team’s oxygen sensor format using the Carver press method 
also provided a variety of challenges. The major issue that arose from the Carver press appeared 
after a failure of the hydraulic unit that was required to apply pressure to the sample. This failure 
resulted in the need to dismantle and reconstruct the hydraulic unit component of the Carver 
press. Before the reconstruction, the sensor dots were being flattened evenly, but after the 
reconstruction, the sensor dots started showing some abnormalities. These abnormalities 
included uneven flattening and the inability to be removed from the Carver press stack-up 
without sticking to the Kapton tape and tearing off the COC. An example of this tearing 
phenomenon is seen in the confocal image in Figure 54 producing cliff like features on the 
sensor dot. 
 
 
Figure 54: Laser confocal topographical image (left), measurement of of height difference between the pressed 
nanoparticle material and the COC base layer (right). The height difference between the nanoparticle materials and 
the COC base layer is determined using software designed to work specifically with the laser confocal microscope 
used throughout the imaging process. 
 
This issue was assumed to be a result of the repaired hydraulic unit applying force off-
center which in turn prevented a uniform distribution of force across the sample. A longer cool 
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down time of the sample post press was experimented with to alleviate the tearing effect; 
however, this did not solve the issue. While this proved to impede the team’s progress, it was not 
a large-scale issue as Draper can fine-tune the Carver press method to meet their needs in the 
future. Even with all of the limitations and issues mentioned above, none proved to be severe 
enough to devalue the results reached by the team. Most of the issues described previously were 
resolved throughout the testing process or will not affect Draper since the issues are local to the 
limitations of the equipment used at WPI, such as the faulty Carver press or the lack of a 
temperature compensating testing platform. 
7.4 Cost Analysis 
Being that the team recommends a concentration of 40 mg/mL, a single vial of the 
nanoparticles would result 0.25 mL of solution, since there are 10 mg of nanoparticles within 
each vial. Each vial costs $292; therefore, the total cost at this concentration would be 
$1168/mL. Based on the worst-case scenario, meaning that the process cannot be scaled down to 
any extent, the project would continue working with individual dots of 3 µL in volume; this 
would result in a total volume of 288 µL. At this scale, the total cost of nanoparticle solution 
within a single microfluidic device would be $336.39. Assuming the ideal range of 300-800 µm 
diameter dots, the dot volumes would span between 0.0007 and 0.0050 µL, assuming a 
cylindrical approximation of dot volume. This means that the total volume divided across an 
array of 96 dots would span between 0.0678 and 0.4825 µL. Assuming these volumes, the price 
per device would span between $0.08 and $0.57. All cost values are reported in USD.  
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CHAPTER 8: CONCLUSIONS AND RECOMMENDATIONS 
8.1 Final Results and Impact 
Thorough testing led the team to produce a result that satisfied nearly all of the objectives 
set by Draper. The final design consisted of 3 µL drops of 40 mg/mL nanoparticle solution 
pressed into the COC via a Carver press at the conditions of 120oC at 450 psi for 15 minutes. The 
sensing format was required to be biocompatible, optically clear for imaging cells, accurate, 
adaptable for future iterations, and is compatible with automation efforts, but further testing is 
required to determine if the nanoparticles are able to function in a cellular environment for the 
duration of up to 14 days continuously. 
Assessments of optical clarity via the use of the inverted confocal microscope were 
conducted on all iterations of the format, and the final sensing format proved to be the best 
combination of clarity, signal intensity, and concentration. The optical clarity was primarily 
modified through the use of the Carver press which helped the team determine that 120oC at 450 
psi for 15 minutes were the best conditions for producing optically clear sensing formats. Even 
though the nanoparticles leave a green tinge on the surface of the COC, it does not hinder the 
process of imaging cells. 
The final sensing format proved to be accurate through Piccolo2 testing since the format 
produced a signal intensity greater than 50 mV as well as the expected oxygen readings. While 
this phase of testing could benefit from further validation with a larger sample size, it still meets 
the goals set by the project allowing Draper to utilize it in their 96 well format. 
The team’s method was designed to be flexible such that the sensor format could be 
applied in multiple ways, with various geometries, from manual deposition to automated 
94 
 
processes. Additionally, the sensing format is able to function in a variety of temperatures and 
lighting conditions while being unreactive in common biological environments. 
Overall, the team’s final sensing format will enable Draper to add another analytical 
method to their existing organ-on-a-chip system. With oxygen data, Draper will be able to assess 
the health of cells being tested within the organ-on-a-chip system, which is essential for 
understanding the effects of various drugs or other conditions, such as temperature, on the cells. 
Additionally, the oxygen sensing capabilities will provide Draper’s system with an advantage 
over the rest of the market since many systems are unable to produce both accurate oxygen 
percentage data and large-scale replicates for testing. In the short term, the new sensing format 
will propel Draper’s development of the 96 well format by allowing Draper to acquire live and 
accurate data from their iterative design correlated to cell health. In the long term, the developed 
sensing format could become a staple in Draper’s organ-on-a-chip systems, as oxygen sensing is 
a valuable analyte for understanding the health of cells with respect to the experimental variable. 
8.2 Recommendations and Future Work 
Throughout the development of the new sensing format, many options for optimization 
were explored; however, some were determined to be out of the time range or scope of the 
project. While not all of these options were worthy of pursuing, the ones that were, have become 
recommendations and possibilities for future work. Recommendations for Draper are based off 
observations the team has made over the duration of the project and help outline the conditions 
that can produce the best results. Future work is explained as action items, which may be 
advantageous for Draper to act on to improve the oxygen sensing system or its means of data 
acquisition. 
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Based off the team’s testing, it is recommended that Draper adopts the oxygen sensing 
format utilizing PyroScience nanoparticles which have been pressed at 120oC and 450 psi for 15 
minutes via the use of a Carver press. This combination of factors results in a format that meets 
Draper’s goals and acts as a foundation for future testing and iterations to build off for further 
optimization. With this recommendation, the team also recommends that Draper build a 
relationship with PyroScience such that purchasing nanoparticles in bulk will reduce the overall 
cost. With a deal like this in place the promise of utilizing nanoparticles in the long term 
becomes much more feasible and cost effective.  
One of the most notable issues with the current oxygen sensing data is its high variability 
due to the Piccolo2’s sensitivity and inability to adjust to temperature fluctuations. To remove 
this limitation, the team recommends that Draper employ the use of the FireStingO2 or similar 
technology developed in house which has the ability to normalize the incoming oxygen 
percentage data with respect to temperature. This would allow for more meaningful and accurate 
oxygen percentage data to be acquired without the threat of temperature variation interfering 
with data collection. In addition to this, Draper’s LED based optical sensing system, which has 
been developed in conjunction with this project, requires characterization with the team’s 
recommended sensing format. Basic tests such as two-point calibration with known standards 
and duration testing over a span of 14 days would provide Draper with important information on 
the accuracy of their custom sensing system. In addition, the team recommends that all future 
work involves multiple iterations of testing to prevent any complications or deviations due to the 
small testing sample size of the studies outlined in this report. Performing multiple iterations of 
testing would remove the heightened effect that outliers play in the analysis of results. 
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For more possible tests in the future, the team recommends that Draper explore the use of 
toluene as a co-solvent for both the COC they are using as well as the structural polymer of the 
nanoparticles based on observations during testing. By dissolving these two together and letting 
them solidify it may be possible to produce a layer of the nanoparticle solution that is embedded 
on to the surface of the COC, thus removing the need for bonding using a Carver press. Tests to 
achieve this vision include dropping toluene onto a dried drop of nanoparticles on the COC. 
Ideally, the drop would melt the COC and nanoparticles such that only the top about 20 μm are 
affected. This would allow the nanoparticles to embed themselves into the COC such that they 
are still exposed to the environment and do not cause serious surface deformations, which could 
promote turbulence when testing with flow. 
The removal of the reliance on a Carver press will also improve the prospect of scaling 
the sensing system up to the full 96 well platform, which leads into another avenue for future 
work. While the team was able to develop a sensor format that is highly adaptable, the team was 
unable to extensively test means of scaling the format up. Since the final system has 96 wells, the 
first tests should be centered on automating the process of dispensing 3 μL drops of the 10 
mg/mL nanoparticle solution on a piece of COC in the patter of a 96 well plate. This can be 
accomplished by using BioTek’s MultiFlo FX, Thermo Scientific’s Multidrop Combi nL 
Reagent Dispenser, or Vermes’s Micro Dispensing Valve - MDV 3200A to automate the ejection 
of drops as mentioned in Section 6.7 Manufacturability and Sustainability. The means of 
automation should then be confirmed to work at a smaller scale and higher resolution to achieve 
the desired 300-800 μm droplets with a placement tolerance of 100 μm. Assuming a cylindrical 
approximation of the flattened droplets and a desired height of 10 μm, the droplets must span 
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between 0.7 nL and 5 nL in volume to achieve diameters between 300 μm and 800 μm. Thus, the 
selected device must be able to operate on the nanoliter scale.  
 Another recommendation would be exploring the use of the hydrophobic dye, which has 
a different composition and fabrication process compared to its hydrophilic counterpart. During 
the span of this project, the creator of these dyes provided the team with predeposited drops of 
the hydrophobic dye, which proved to have exceptional optical clarity and signal intensity when 
the Piccolo2 was directly in contact with the drop. Figure 55 below shows the potential for the 
hydrophobic dye’s clarity as it barely hinders the image quality of the histological slide. Further 
testing using the dye could result in a better alternative to the nanoparticles. 
 
 
Figure 55: Hydrophobic dye in the optical path of a histological slide containing human skin. The hydrophobic dye 
droplet is located off to the right of the image. 
 
The team also recommends a fabrication process for Draper to incorporate the final 
design into their current organ-on-a-chip device. This process is illustrated in Appendix I: 
Processing Protocol. First, a piece of COC, cut to size, must be oxygen plasma treated for one 
hour. Directly after this process, a desired volume of prepared nanoparticle solution at a 
concentration of 40 mg/mL should be deposited on the COC surface in the pattern of the 96 well 
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device. Using the Carver press stack up previously described, the sensor format should be 
bonded to the COC under a pressure of 450 psi and a temperature of 120°C for 15 minutes. After 
this step, the prepared sheet can then be incorporated into the final thermal bond of Draper’s 
device. A step-by-step protocol for this process is illustrated in Appendix I: Processing Protocol.  
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APPENDIX A: GANTT CHART 
 
Figure 56: The team’s Gantt chart. 
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APPENDIX B: WORK BREAKDOWN CHART 
 
Figure 57: The team’s work breakdown chart.  
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APPENDIX C: DYE 
To use the hydrophilic form of the indicator dye, the two components must be combined 
with a mixture of ethanol and DI water in a 9:1 ratio. To use the hydrophobic form, the dye 
component must be combined with a mixture of tetrahydrofuran, referred to as THF, and toluene 
in a 7:3 ratio. The hydrophilic form of the dye results in a homogeneous suspension while the 
hydrophobic form results in a clear solution. The hydrophilic form of the dye is shown in Figure 
58 below. 
 
 
Figure 58: The hydrophilic form of the dye-based indicator. This dye was prepared using a combination of 200 proof 
ethanol and DI water in a 9:1 ratio. 
 
The prominent green color shown in the suspension in Figure 58 indicates that there was 
a high concentration of the indicator present in the sample. Being that the hydrophilic and 
hydrophobic forms of the dye-based indicator solutions require the use of different chemicals to 
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generate the liquid form of the dye, the team explored the effects that these chemicals have 
individually on the COC material used to construct the final device. As mentioned, the 
hydrophilic form of the dye requires the use of ethanol and DI water. Being that DI water has 
been used extensively in previous tests and has shown no significant effects on the COC, the 
team focused on studying the effects of ethanol. Preliminary tests showed no significant effects 
on the integrity of the COC material, although a cloudy film was left behind after the ethanol 
evaporated as seen in Figure 59 below. 
 
 
Figure 59: The surface of COC following the evaporation of 5 µL of ethanol at 10X. There is obvious opacity that is 
generated as the ethanol evaporates quickly from the surface of the COC. 
 
The hydrophobic form of the dye requires a mixture of toluene and tetrahydrofuran, THF. 
To ensure that the use of the hydrophobic form of the dye will not compromise the final device, 
the team studied the effects of both of the aforementioned chemicals on COC. After applying 
toluene to the surface of the COC, a tacky layer began to form creating an extremely sticky 
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surface. Additionally, there was a significant amount of degradation of the COC visible when the 
sample was analyzed under 10X magnification microscopy, which can be Figure 60. 
 
 
Figure 60: The surface of the COC following the evaporation of 5 µL of toluene at 10X. The toluene generates a 
rough topography across the surface of the COC. 
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APPENDIX D: MATLAB CODE FOR PICCOLO2 DATA ANALYSIS 
%% MQP PiccolO2 Data Analysis 
% Emma MacIntyre 
% November 22, 2017 
  
clear; clc; close all; 
  
%read raw PiccolO2 data from a .txt file 
%fileName = input('Enter filename in quotes: '); 
fileName = 'pdmsencap121317.txt' 
data = readtable(fileName); %reads data as a table 
time = str2double(data.Var3(2:end)); %create column vector of time data 
%time =data.Time(2:end); %create column vector of time data 
o2Conc = str2double(data.Oxygen(2:end)); %column vector of oxygen conc 
%dphi = str2double(data.dphi(2:end)); %column vector of dphi values 
intensity = str2double(data.Intensity(2:end)); %column vector of intensity 
%intensity = data.intensity(2:end); %column vector of intensity 
reps = input('Enter replicates:'); 
count = 1; 
  
while count < reps + 1 
 %identify data section to analyze 
 startTime = input('Enter start time: '); 
 endTime = input('Enter end time: '); 
 stringTitle = input('Enter Title: '); 
 %startTime = startTime +1; %correct index since vector starts at zero 
 %endTime = endTime +1; %correct index since vector starts at zero 
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 %extract oxygen and time data to plot 
 timePlot = time(startTime:endTime); 
 o2ConcPlot = o2Conc(startTime:endTime); 
 intensityPlot = intensity(startTime:endTime); 
  
 %plot oxygen conc versus time 
 figure 
 hold on 
 plot(timePlot,o2ConcPlot,'-x'); 
 xlabel('Time (s)'); 
 ylabel('Oxygen Concentration (%O2)'); 
 title(stringTitle); 
  
 %linear fit 
 linearFit = polyfit(timePlot,o2ConcPlot,1); 
 yfit = polyval(linearFit, timePlot); 
 plot(timePlot,yfit,'--'); 
 yresid = o2ConcPlot - yfit; 
 SSresid = sum(yresid.^2); 
 SStotal = (length(o2ConcPlot)-1) * var(o2ConcPlot); 
 rsq = 1 - SSresid/SStotal 
  
 averageO2(count) = sum(o2ConcPlot)/length(o2ConcPlot); 
 rangeO2(count) = max(o2ConcPlot) - min(o2ConcPlot); 
 averageSigIn(count) = sum(intensityPlot)/length(intensityPlot); 
 slope(count)= linearFit(1); 
  
 count = count +1; 
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end 
  
%calculate parameters 
averageConc= sum(averageO2)/reps; 
fprintf('Average O2: %f %%\n',averageConc); 
averageRange= sum(rangeO2)/reps; 
fprintf('Range O2: %f %%\n',averageRange); 
averageIn= sum(averageSigIn)/reps; 
fprintf('Average Singal Intensity: %f mV\n',averageIn); 
averageSlope = sum(slope)/reps; 
fprintf('Average Slope: %f %%O2/s\n',averageSlope);  
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APPENDIX E: DILUTION TESTING OF NANOPARTICLES 
The team obtained oxygen measurements for each sample by placing the plate in a 
controlled temperature environment, which varied between 21.1°C and 21.8°C, based on 
inaccuracies in initial benchtop testing due to temperature fluctuation. In this environment, the 
plate rested on a metal shelf as seen in Figure 61. Team members fixed the fiber optic between 
the grids of the metal shelf and placed the well plate on the top of the cable. The fiber was held 
flush against the bottom of the plate and readings were taken for both settled and mixed samples 
at nanoparticle amounts ranging from 0.5 mg to 0.025 mg for 120 seconds. Between each 
reading, the box was opened from the top, as seen in Figure 61A, and the well plate was 
manually moved to align the next testing well with the fiber optic cable. For the mixed samples, 
the solution was agitated between each replicate of testing using a micropipette. 
 
 
Figure 61: The fiber optic cable fixed in place under a metal grate and the well plate was moved to the cable for each 
trial. The fiber optic cable is attached to the grates of the stand using a custom prototyped holder and adhesive tape. 
The temperature is monitored within the enclosure using a standard thermoprobe.  
 
The change in percent oxygen versus time for the temperature controlled dilution test can 
be seen in Figure 62A. The team concluded that the mixed replicates had an oxygen percent drop 
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off much quicker than the settled replicates, which can be correlated to a decrease in signal 
intensity. In both cases, the drop-off in percent oxygen occurred after the signal intensity fell 
below 50 mV, which is the minimum signal intensity required for accurate reading per the 
Piccolo2’s specifications. All values obtained using the Piccolo2 involved taking measurements at 
the area with the approximate highest density of nanoparticles. In terms of signal intensity, the 
mixed samples consistently showed a lower signal intensity than the settled particles. On the 
other hand, only two samples in the settled study had too low of a signal intensity for accurate 
readings. This is illustrated in Figure 62B, below. 
 
 
Figure 62: Percent of oxygen versus concentration (A) and signal intensity versus concentration (B) graphs for both 
mixed and settled dilution trials. There are obvious trends indicating that the settled mixtures provide much higher 
signal intensity readings, which is expected since the particles will be closer to the source of excitation. The oxygen 
percentage readings, when stabilized, are relatively constant among the two. 
 
In terms of characterization, the temperature controlled testing illustrated that the 
Piccolo2 shows a decay in percent oxygen readings for each replicate with time when signal 
intensity is adequate, as seen in Figure 63A. As the signal intensity decreases below 50 mV, the 
oxygen readings tend to increase steadily as illustrated in Figure 63B. 
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Figure 63: Oxygen percentage versus time for 0.4 mg (left) and 0.025 mg (right) concentration trials for mixed 
testing. Graph A illustrates a constant decrease in oxygen percentage with adequate signal intensity, while the graph 
B illustrates an increase in oxygen percentage with a poor signal intensity 
 
A major goal of the dilution testing was to determine the minimum amount of 
nanoparticles required to attain the appropriate signal intensity. The concentration tests 
illustrated the anticipated relationship of a decrease in signal intensity in a relatively linear 
fashion as a function of nanoparticle concentration. During testing, a signal intensity lower than 
50 mV was found when there were less than 0.075 mg of nanoparticles in the solution. Thus, it 
was concluded that 0.075 mg of nanoparticles was the minimum amount required to obtain 
accurate readings in this testing format. This amount of nanoparticles was deposited in a 
polystyrene 96-well plate, which has a well diameter of 9 mm and a corresponding area of 63.62 
mm2. This results in a minimum particle density of 0.0012 mg/mm2.  
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APPENDIX F: NANOPARTICLES IN PDMS 
After allowing a drop of PDMS to cure over a dried droplet of nanoparticles, a blade was 
used to peel the cured PDMS droplets off the glass slide. The PDMS droplets were then bonded 
in a 24 well plate with the nanoparticles open to the air using an additional drop of PDMS as 
illustrated in Figure 64. 
 
 
Figure 64: PDMS was peeled off the glass slide and bonded to the bottom of a polystyrene well plate using PDMS. 
The green dot in the center of the top well represents the nanoparticle solution. This dot is surrounded by a layer of 
PDMS, which is outlined in the light gray color for emphasis. 
 
When peeling the PDMS stamps off the glass slide it was noted that not all of the 
nanoparticles transferred from the glass slide to the PDMS, leaving a noticeable residue behind, 
as illustrated in Figure 65. Figure 65A shows the residue transferred to the PDMS after stamping, 
while Figure 65B shows the residue left behind on the glass slide, although it appeared that more 
nanoparticles were transferred to the PDMS stamp than not. The Piccolo2 was then used to 
measure the signal intensity of this sensor format. The signal intensity values for all 
concentrations in this PDMS peel method were found to be below the required 50 mV threshold, 
rendering this method ineffective. 
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Figure 65: PDMS peel testing all imaged at 10X magnification of an inverted microscope. A) 3 µL, 5 mg/mL 
nanoparticle droplet remaining on PDMS surface after being peeled off. B) Residual 3 µL, 5 mg/mL drop remaining 
on glass slide after PDMS was peeled off the surface 
 
Three other fabrication methods using nanoparticles and PDMS were tested as illustrated 
in Figure 66. The first method, seen in Figure 66A, involved dropping PDMS on a glass slide 
and mixing a drop of nanoparticles into the PDMS. It was found that it was not possible to obtain 
a uniform nanoparticle distribution using this method, as illustrated by the nanoparticle clumps 
visible in Figure 66A. Figure 66B illustrates the encapsulation of nanoparticles between PDMS. 
A drop of PDMS was placed on a glass slide, a drop of nanoparticle solution was placed on top 
of the PDMS, and then more PDMS was placed on top of the nanoparticle solution. Finally, in 
Figure 66C, a drop of nanoparticle solution was placed on the surface of a PDMS droplet and the 
PDMS was allowed to cure. 
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Figure 66: PDMS testing concepts all imaged at 10X magnification of an inverted microscope. A) 3 µL of 5mg/mL 
nanoparticle solution mixed into PMDS. B) 3 µL of 5 mg/mL nanoparticle droplet encapsulated in PDMS. C) Drop 
of 5 mg/mL nanoparticle solution on surface of PDMS droplet 
 
For the study illustrated in Figure 66A, the signal intensity was not readable and oxygen 
percentage readings were unable to be collected. The average signal intensity for the 
encapsulated study illustrated in Figure 66B was 112.06 mV. Finally, the highest signal intensity 
of the three PDMS tests as illustrated in Figure 66C was determined to be 199.73 mV. The area 
of the droplet in Figure 66B was 0.681 mm2 and the area of the droplet in Figure 66C is 1.602 
mm2. This corresponds to nanoparticle concentrations of 0.022 mg/mm2 and 0.0094 mg/mm2 for 
Figure 66B and Figure 66C respectively. Both of these determined particle densities were much 
higher than the minimum particle density of 0.0012 mg/mm2 determined from the settled dilution 
testing. This makes sense since these trials had almost double the signal intensity compared to 
the corresponding dilution trial. 
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APPENDIX G: NANOPARTICLE DRIED FILM 
To test the effects of detergent and salt on the dispersion of the nanoparticles, the team 
created two separate mixtures: one of the nanoparticles in DI water and table salt and another of 
the nanoparticles in DI water and dish detergent. After thorough mixing of each of these 
solutions, the team placed a 3 µL droplet of each solution on pieces of COC. These droplets were 
allowed to dry completely and were then imaged under 10X magnification. As shown in Figure 
67, the nanoparticle solution was much more evenly dispersed when mixed using detergent and 
salt, as compared to a control of DI water. 
 
   
Figure 67: Dried nanoparticle solution with and dish detergent at 10X (left) and dried nanoparticle solution with salt 
at 10X (right). As shown, both the detergent mixture and the salt mixture fostered the distribution of the 
nanoparticles within the solution and lessened the amount of clumping. 
 
 The nanoparticles, when mixed using a dish detergent base, spread evenly across the 
surface of the COC. However, because this indicator must be utilized in a cellular environment, 
the team did not want to further pursue a method in which the chemistry of the indicator solution 
was heavily altered. Furthermore, there was an obvious presence of salt crystals located 
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surrounding the nanoparticles in the dried droplet of the DI water, salt, and nanoparticle mixture. 
Being that this indicator will be used in a cellular environment, the team decided that the salinity 
of the solution should not be greatly modified and the presence of salt crystals must be avoided. 
Due to this, the team chose to not pursue the use of salt as means of dispersing the nanoparticle 
solution.  
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APPENDIX H: LASER CONFOCAL ANALYSIS 
 
Figure 68: Laser confocal analysis of sample N1 using 50X lens. Area of sample being analyzed by laser confocal 
(left) and topographic map of area of interest (right). 
 
 
Figure 69: Laser confocal analysis of sample N4 using 50X lens. Area of sample being analyzed by laser confocal 
(left) and topographic map of area of interest (right).  
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APPENDIX I: PROCESSING PROTOCOL 
 
Figure 70: Recommended process for the incorporation of the nanoparticle design into Draper’s organ-on-a-chip 
device.  
 
Detailed Protocol 
1. Obtain raw PyroScience nanoparticles.* 
a. Add 0.25 mL of DI water to a 10 mg vial of raw nanoparticles.  
b. Sonicate the vial for 10 minutes or until the solution is mixed such that no 
nanoparticles are visible to the naked eye.  
*Store nanoparticles shielded from light in a chilled environment when not using.  
2. Prepare the COC for the deposition of the sensor format. 
a. Cut a piece of raw material to the dimensions of a standard 96 well plate. 
b. Remove the protective covers from both sides of the COC. 
c. Place COC in an oxygen plasma chamber for 1 minute of exposure. 
3. Set-up the desired automated system for deposition of the sensor format. 
a. Transfer solution containing the sensor format into a 96 well plate.  
b. Program the automated machine to drop the desired volume and positioning of 
each drop in the 96 well format.  
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c. Allow the solution to dry. 
4. Bond the deposited sensor format to the COC using Carver press method.  
a. Cut two ⅛’’ pieces of aluminum to dimensions slightly bigger than the sheet of 
COC.  
b. Cut two compliance layers (rubber would suffice) to a size slightly bigger than the 
aluminum sheets.  
c. Coat aluminum pieces in Kapton ensuring to minimize any air bubbles or 
particulates under the surface.  
d. Transfer COC sheet with deposited sensor format onto one of the Kapton covered 
pieces of aluminum.  
e. Place other aluminum piece on top and tape sides with Kapton tape to prevent 
sliding of the aluminum layers.  
f. Place the rubber pieces on either side of the aluminum.  
g. Carefully transfer testing stack-up to a Carver press machine with heated platens. 
h. Place the sample between the platens in the center and apply a small amount of 
pressure such that the stack up is in contact with both platens and heat the press to 
120°C. 
i. Once the Carver press is heated to 120°C, apply a force of 1000 lbs on the Carver 
press which should equal a 450 psi pressure on the sample.  
j. After 15 minutes, remove pressure and turn the Carver press off.  
k. Let the sample cool for 12 hours and carefully peel the COC sheet from the stack-
up.  
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